CK1D
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S158 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | TDRGSGKKRGFAFVTFDDHDsVDKIVIQKYHTVNGHNCEVR |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A6NMY6 | S127 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| A6NMY6 | T123 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| A6NMY6 | T31 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKGV |
| A6NMY6 | Y30 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKG |
| O00165 | S192 | Sugiyama | HAX1 HS1BP1 | VWPMDPHPRtREDNDLDsQVsQEGLGPVLQPQPKSYFKsIS |
| O00165 | T181 | Sugiyama | HAX1 HS1BP1 | GsQRPFHRFDDVWPMDPHPRtREDNDLDsQVsQEGLGPVLQ |
| O00170 | S43 | Sugiyama | AIP XAP2 | GELPDFQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELI |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00299 | T222 | Sugiyama | CLIC1 G6 NCC27 | AFRGVHRYLsNAyAREEFAstCPDDEEIELAyEQVAKALK_ |
| O00469 | S367 | Sugiyama | PLOD2 | FDKAKHEIKTIKIVGPEENLsQAEARNMGMDFCRQDEKCDY |
| O00566 | S171 | Sugiyama | MPHOSPH10 MPP10 | RAENSSKsDLRKsPVFsDEDsDLDFDISKLEQQSKVQNKGQ |
| O00571 | S70 | Sugiyama | DDX3X DBX DDX3 | KGFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGs |
| O14641 | S143 | SIGNOR|PSP | DVL2 | ERtsGIGDsRPPsFHPNVsssHENLEPEtEtEsVVsLRRER |
| O14641 | T224 | SIGNOR|PSP | DVL2 | EStSLGDsDEEDTMSRFSSStEQssASRLLKRHRRRRKQRP |
| O14980 | S450 | Sugiyama | XPO1 CRM1 | VLVVENDQGEVVREFMKDTDsINLyKNMRETLVyLTHLDyV |
| O15055 | S480 | SIGNOR | PER2 KIAA0347 | QELTEQIHRLLLQPVPHSGSsGYGSLGSNGSHEHLMSQTSS |
| O15055 | S662 | PSP | PER2 KIAA0347 | NSRTGVGTHLTSLALPGKAEsVAsLTsQCsYSsTIVHVGDK |
| O15055 | S665 | PSP | PER2 KIAA0347 | TGVGTHLTSLALPGKAEsVAsLTsQCsYSsTIVHVGDKKPQ |
| O15055 | S668 | PSP | PER2 KIAA0347 | GTHLTSLALPGKAEsVAsLTsQCsYSsTIVHVGDKKPQPEL |
| O15055 | S977 | iPTMNet | PER2 KIAA0347 | RQPCACPATRATPPSAMGRAsPPLFQSRSSSPLQLNLLQLE |
| O15143 | S311 | Sugiyama | ARPC1B ARC41 | SSQRGLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVsQ |
| O15143 | T315 | Sugiyama | ARPC1B ARC41 | GLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVL |
| O15169 | S46 | SIGNOR | AXIN1 AXIN | PGEEGELVSTDPRPASYSFCsGKGVGIKGETSTATPRRSDL |
| O15460 | T532 | Sugiyama | P4HA2 UNQ290/PRO330 | WVSNKWFHERGQEFLRPCGstEVD_________________ |
| O15523 | S70 | Sugiyama | DDX3Y DBY | KGFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSG |
| O43242 | T48 | Sugiyama | PSMD3 | PPPAPQDVEMKEEAAtGGGstGEADGKtAAAAAEHsQRELD |
| O43242 | T55 | Sugiyama | PSMD3 | VEMKEEAAtGGGstGEADGKtAAAAAEHsQRELDtVtLEDI |
| O43312 | S322 | SIGNOR|PSP | MTSS1 KIAA0429 MIM | RSSNLAQQAPVRLSsVSSHDsGFISQDAFQSKSPSPMPPEA |
| O43399 | T23 | Sugiyama | TPD52L2 | sAGQDINLNsPNKGLLsDsMtDVPVDTGVAARtPAVEGLTE |
| O43633 | S203 | Sugiyama | CHMP2A BC2 CHMP2 | PSTGGSLSVAAGGKKAEAAAsALADADADLEERLKNLRRD_ |
| O43707 | S447 | Sugiyama | ACTN4 | AWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAAHQ |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43719 | S702 | Sugiyama | HTATSF1 | EDADGKEVEDADEKLFEDDDsNEKLFDEEEDssEKLFDDsD |
| O43719 | S714 | Sugiyama | HTATSF1 | EKLFEDDDsNEKLFDEEEDssEKLFDDsDERGTLGGFGSVE |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43847 | S96 | Sugiyama | NRDC NRD1 | SRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYRYI |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S300 | Sugiyama | CALU | NKDGKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF_____ |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | T303 | Sugiyama | CALU | GKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF________ |
| O43896 | S674 | Sugiyama | KIF1C KIAA0706 | YRKEKEEADLLLEQQRLyADsDsGDDsDKRsCEESWRLISS |
| O43896 | S684 | Sugiyama | KIF1C KIAA0706 | LLEQQRLyADsDsGDDsDKRsCEESWRLISSLREQLPPTTV |
| O60231 | S112 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | EKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRKHLRKKR |
| O60231 | S116 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | SYRLLEDsEEssEEtVsRAGsSLQKKRKKRKHLRKKREEEE |
| O60264 | S825 | Sugiyama | SMARCA5 SNF2H WCRF135 | ELPNAAQAQKEEQLKIDEAEsLNDEELEEKEKLLTQGFTNW |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60664 | S225 | Sugiyama | PLIN3 M6PRBP1 TIP47 | PLTDAELARIAtsLDGFDVAsVQQQRQEQSyFVRLGsLSER |
| O60664 | T145 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VssKVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKT |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S113 | Sugiyama | EIF5B IF2 KIAA0741 | sKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTAKPKVEM |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O75122 | S14 | Sugiyama | CLASP2 KIAA0627 | _______MAMGDDKsFDDEEsVDGNRPssAAsAFKVPAPKT |
| O75122 | S974 | Sugiyama | CLASP2 KIAA0627 | RsQEDMNEPLKRDSKKDDGDsMCGGPGMSDPRAGGDATDss |
| O75581 | S1490 | PSP | LRP6 | SSSSssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPs |
| O75581 | T1479 | SIGNOR | LRP6 | PYDRAHVTGASSSSSssTKGtYFPAILNPPPsPAtERsHYT |
| O75581 | T1493 | SIGNOR | LRP6 | SssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPsTHR |
| O75821 | S217 | Sugiyama | EIF3G EIF3S4 | PGELEPVQAtQNKtGKYVPPsLRDGAsRRGESMQPNRRADD |
| O75821 | S223 | Sugiyama | EIF3G EIF3S4 | VQAtQNKtGKYVPPsLRDGAsRRGESMQPNRRADDNAtIRV |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O75822 | T157 | Sugiyama | EIF3J EIF3S1 PRO0391 | GVNNAVyGIDAMNPSSRDDFtEFGKLLKDKITQYEKSLYYA |
| O95218 | S153 | Sugiyama | ZRANB2 ZIS ZNF265 | KYRGKAVGPAsILKEVEDKEsEGEEEDEDEDLsKyKLDEDE |
| O95218 | S165 | Sugiyama | ZRANB2 ZIS ZNF265 | LKEVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNL |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95747 | S347 | Sugiyama | OXSR1 KIAA1101 OSR1 | RLHKtEDGGWEWsDDEFDEEsEEGKAAIsQLRsPRVKESIS |
| O95757 | S508 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | GIFSVASASVIEKQNLEGDHsDAPMETEtsFKNENKDNMDK |
| O95831 | S116 | Sugiyama | AIFM1 AIF PDCD8 | NERIsGLGLtPEQKQKKAALsAsEGEEVPQDKAPSHVPFLL |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S115 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | FLKDCVGPEVEKACANPAAGsVILLENLRFHVEEEGKGKDA |
| P00558 | S415 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGGAsLELLEGKVLPGVDALsNI__________________ |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P02786 | S10 | Sugiyama | TFRC | ___________MMDQARsAFsNLFGGEPLsytRFsLARQVD |
| P02786 | S7 | Sugiyama | TFRC | ______________MMDQARsAFsNLFGGEPLsytRFsLAR |
| P02810 | S24 | SIGNOR | PRH1; PRH2 | ILLSVALLAFSSAQDLDEDVsQEDVPLVISDGGDsEQFIDE |
| P04040 | T441 | Sugiyama | CAT | HSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCE |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04637 | S20 | SIGNOR|PSP | TP53 P53 | _MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQAM |
| P04637 | S9 | PSP | TP53 P53 | ____________MEEPQsDPsVEPPLsQEtFsDLWKLLPEN |
| P04637 | T18 | SIGNOR|ELM|iPTMNet|PSP | TP53 P53 | ___MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQ |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P05023 | S217 | Sugiyama | ATP1A1 | DRIPADLRIIsANGCKVDNssLtGESEPQtRsPDFtNENPL |
| P05187 | S114 | Sugiyama | ALPP PLAP | DRFPYVALSKTYNVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P05187 | S434 | Sugiyama | ALPP PLAP | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETH |
| P05187 | T117 | Sugiyama | ALPP PLAP | PYVALSKTYNVDKHVPDsGAtATAYLCGVKGNFQTIGLSAA |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05198 | T284 | Sugiyama | EIF2S1 EIF2A | EKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVDGDD |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S304 | Sugiyama | RPLP0 | AttAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05556 | S509 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | CRCNEGRVGRHCECstDEVNsEDMDAYCRKENSSEICSNNG |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07237 | S449 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | ANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKF |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07355 | S127 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | T123 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| P07355 | T31 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKGV |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y30 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKG |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S1473 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | CEDWIKKtTARDQDLEPGAPsMGAKSLCIPFKPLCELQPGA |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S543 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKKQEE |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T540 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yMIEPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKK |
| P07900 | T624 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIE |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S532 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yMtEPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T537 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEESK |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08758 | S135 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | AsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRMLVV |
| P08758 | S136 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | sRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRMLVVL |
| P08758 | S37 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAF |
| P08758 | T33 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | PGFDERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEI |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08865 | S75 | Sugiyama | RPSA LAMBR LAMR1 | WEKLLLAARAIVAIENPADVsVIssRNtGQRAVLKFAAAtG |
| P08865 | S78 | Sugiyama | RPSA LAMBR LAMR1 | LLLAARAIVAIENPADVsVIssRNtGQRAVLKFAAAtGAtP |
| P08865 | S79 | Sugiyama | RPSA LAMBR LAMR1 | LLAARAIVAIENPADVsVIssRNtGQRAVLKFAAAtGAtPI |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09497 | S121 | Sugiyama | CLTB | ESIRKWREEQRKRLQELDAAsKVtEQEWREKAKKDLEEWNQ |
| P09497 | T124 | Sugiyama | CLTB | RKWREEQRKRLQELDAAsKVtEQEWREKAKKDLEEWNQRQs |
| P09651 | S158 | Sugiyama | HNRNPA1 HNRPA1 | TDRGsGKKRGFAFVTFDDHDsVDKIVIQKyHtVNGHNCEVR |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P09972 | S132 | Sugiyama | ALDOC ALDC | GVVPLAGtDGEtttQGLDGLsERCAQYKKDGADFAKWRCVL |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG47 | T55 | Sugiyama | UBB | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P0CG48 | T55 | Sugiyama | UBC | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P10636 | S396 | SIGNOR | MAPT MAPTL MTBT1 TAU | ARMVSKSKDGtGSDDKKAKTsTRSsAKtLKNRPCLsPKHPT |
| P10636 | S519 | SIGNOR | MAPT MAPTL MTBT1 TAU | PPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTRE |
| P10636 | S721 | SIGNOR | MAPT MAPTL MTBT1 TAU | AKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGsIDMVDsPQ |
| P10636 | T522 | SIGNOR | MAPT MAPTL MTBT1 TAU | SGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKK |
| P10696 | S111 | Sugiyama | ALPG ALPPL ALPPL2 | DRFPYVALSKTYSVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P10696 | S431 | Sugiyama | ALPG ALPPL ALPPL2 | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETH |
| P10696 | T114 | Sugiyama | ALPG ALPPL ALPPL2 | PYVALSKTYSVDKHVPDsGAtATAYLCGVKGNFQTIGLSAA |
| P10809 | T422 | Sugiyama | HSPD1 HSP60 | AVLKVGGtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGC |
| P11047 | S942 | Sugiyama | LAMC1 LAMB2 | GFYNLQSGQGCERCDCHALGstNGQCDIRTGQCECQPGITG |
| P11142 | S221 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHF |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12277 | S163 | Sugiyama | CKB CKBB | PPHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAE |
| P12830 | S844 | SIGNOR|ELM|PSP | CDH1 CDHE UVO | APPYDSLLVFDYEGsGsEAAsLSsLNssEsDKDQDYDYLNE |
| P13637 | S207 | Sugiyama | ATP1A3 | DRVPADLRIISAHGCKVDNssLtGESEPQTRSPDCTHDNPL |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13667 | S154 | Sugiyama | PDIA4 ERP70 ERP72 | VsGyPtIKILKKGQAVDyEGsRtQEEIVAKVREVSQPDWTP |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13797 | S120 | Sugiyama | PLS3 | KEGICALGGTsELssEGtQHsysEEEKyAFVNWINKALEND |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13797 | T117 | Sugiyama | PLS3 | INRKEGICALGGTsELssEGtQHsysEEEKyAFVNWINKAL |
| P13804 | S192 | Sugiyama | ETFA | sFDAAATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPEL |
| P13861 | S80 | Sugiyama | PRKAR2A PKR2 PRKAR2 | GHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRVsV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13861 | T104 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVIHPKTD |
| P13861 | Y105 | Sugiyama | PRKAR2A PKR2 PRKAR2 | DLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVIHPKTDE |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S100 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIR |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14618 | Y105 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIRtGLIK |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15531 | S125 | Sugiyama | NME1 NDPKA NM23 | RGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDyTsC |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17302 | S325 | SIGNOR|iPTMNet | GJA1 GJAL | AsEQNWANysAEQNRMGQAGstIsNsHAQPFDFPDDNQNsK |
| P17302 | S328 | SIGNOR|iPTMNet | GJA1 GJAL | QNWANysAEQNRMGQAGstIsNsHAQPFDFPDDNQNsKKLA |
| P17302 | S330 | SIGNOR|iPTMNet | GJA1 GJAL | WANysAEQNRMGQAGstIsNsHAQPFDFPDDNQNsKKLAAG |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18084 | S507 | Sugiyama | ITGB5 | CECSPGYLGTRCECQDGENQsVyQNLCREAEGKPLCSGRGD |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | T452 | Sugiyama | NCL | AyIEFKTEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQD |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20648 | S228 | Sugiyama | ATP4A | DRVPADIRILAAQGCKVDNssLtGESEPQTRSPECTHESPL |
| P20810 | S575 | Sugiyama | CAST | APPRDtsQsDKDLDDALDKLsDsLGQRQPDPDENKPMEDKV |
| P20810 | S577 | Sugiyama | CAST | PRDtsQsDKDLDDALDKLsDsLGQRQPDPDENKPMEDKVKE |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23434 | S153 | Sugiyama | GCSH | LVNKSCyEDGWLIKMtLsNPsELDELMsEEAyEKYIKSIEE |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P23921 | T774 | Sugiyama | RRM1 RR1 | KEKLKDKEKVSKEEEEKERNtAAMVCsLENRDECLMCGS__ |
| P25054 | S1279 | ELM | APC DP2.5 | IQTYCVEDTPICFSRCSSLSsLSSAEDEIGCNQTTQEADSA |
| P25054 | S1392 | ELM | APC DP2.5 | PPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEPCSG |
| P25054 | S1504 | PSP | APC DP2.5 | DADTLLHFATESTPDGFsCsssLsALsLDEPFIQKDVELRI |
| P25054 | S1505 | PSP | APC DP2.5 | ADTLLHFATESTPDGFsCsssLsALsLDEPFIQKDVELRIM |
| P25054 | S1507 | PSP | APC DP2.5 | TLLHFATESTPDGFsCsssLsALsLDEPFIQKDVELRIMPP |
| P25054 | S1510 | PSP | APC DP2.5 | HFATESTPDGFsCsssLsALsLDEPFIQKDVELRIMPPVQE |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25788 | S250 | Sugiyama | PSMA3 HC8 PSC8 | KDIREEAEKyAKEsLKEEDEsDDDNM_______________ |
| P25788 | Y239 | Sugiyama | PSMA3 HC8 PSC8 | ELTNGRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM____ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26641 | S304 | Sugiyama | EEF1G EF1G PRO1608 | PKstFVLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLWyS |
| P26641 | T302 | Sugiyama | EEF1G EF1G PRO1608 | HLPKstFVLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLW |
| P27348 | S232 | ELM | YWHAQ | KDstLIMQLLRDNLTLWtsDsAGEECDAAEGAEN_______ |
| P27348 | T24 | Sugiyama | YWHAQ | TELIQKAKLAEQAERyDDMAtCMKAVtEQGAELsNEERNLL |
| P27348 | T30 | Sugiyama | YWHAQ | AKLAEQAERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKN |
| P27695 | T19 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | __MPKRGKKGAVAEDGDELRtEPEAKKSKTAAKKNDKEAAG |
| P27707 | S11 | PSP | DCK | __________MAtPPKRsCPsFsAssEGTRIKKISIEGNIA |
| P27707 | S15 | PSP | DCK | ______MAtPPKRsCPsFsAssEGTRIKKISIEGNIAAGKS |
| P27707 | S74 | SIGNOR|PSP | DCK | PVARWCNVQstQDEFEELtMsQKNGGNVLQMMYEKPERWSF |
| P27707 | T72 | PSP | DCK | PEPVARWCNVQstQDEFEELtMsQKNGGNVLQMMYEKPERW |
| P27797 | S189 | Sugiyama | CALR CRTC | THLytLIVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIK |
| P27797 | S193 | Sugiyama | CALR CRTC | tLIVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIKDPDA |
| P27797 | S195 | Sugiyama | CALR CRTC | IVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIKDPDAsK |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | T562 | Sugiyama | CANX | EEGEEKLEEKQKsDAEEDGGtVsQEEEDRKPKAEEDEILNR |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | T129 | Sugiyama | EEF1D EF1D | EARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPA |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P30043 | S198 | Sugiyama | BLVRB FLR SCAN | KHDLGHFMLRCLttDEyDGHstyPsHQyQ____________ |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30085 | S180 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | KPIIDLyEEMGKVKKIDASKsVDEVFDEVVQIFDKEG____ |
| P30086 | S104 | Sugiyama | PEBP1 PBP PEBP | WHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLV |
| P30101 | S155 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ASVPLRTEEEFKKFISDKDAsIVGFFDDsFsEAHsEFLKAA |
| P30101 | S163 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | EEFKKFISDKDAsIVGFFDDsFsEAHsEFLKAASNLRDNYR |
| P30101 | S165 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FKKFISDKDAsIVGFFDDsFsEAHsEFLKAASNLRDNYRFA |
| P30101 | S169 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ISDKDAsIVGFFDDsFsEAHsEFLKAASNLRDNYRFAHTNV |
| P30291 | S212 | SIGNOR|PSP | WEE1 | KSLLSKARGIDSSSVKLRGssLFMDtEKSGKREFDVRQTPQ |
| P31153 | S38 | Sugiyama | MAT2A AMS2 MATA2 | FLFTSESVGEGHPDKICDQIsDAVLDAHLQQDPDAKVACET |
| P31327 | S1090 | Sugiyama | CPS1 | KNGVKIMGTsPLQIDRAEDRsIFsAVLDELKVAQAPWKAVN |
| P31327 | S1093 | Sugiyama | CPS1 | VKIMGTsPLQIDRAEDRsIFsAVLDELKVAQAPWKAVNTLN |
| P31327 | S1159 | Sugiyama | CPS1 | MNVVFSEDEMKKFLEEAtRVsQEHPVVLTKFVEGAREVEMD |
| P31327 | S863 | Sugiyama | CPS1 | LSEPSsTRIyAIAKAIDDNMsLDEIEKLTYIDKWFLYKMRD |
| P31327 | T1156 | Sugiyama | CPS1 | GSAMNVVFSEDEMKKFLEEAtRVsQEHPVVLTKFVEGAREV |
| P31943 | S281 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | GRDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAt |
| P31946 | T32 | Sugiyama | YWHAB | AKLAEQAERyDDMAAAMKAVtEQGHELsNEERNLLsVAyKN |
| P31947 | S69 | Sugiyama | SFN HME1 | KNVVGGQRAAWRVLSsIEQKsNEEGsEEKGPEVREYREKVE |
| P31947 | S74 | Sugiyama | SFN HME1 | GQRAAWRVLSsIEQKsNEEGsEEKGPEVREYREKVETELQG |
| P31948 | S459 | Sugiyama | STIP1 | EAMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRH |
| P31948 | S460 | Sugiyama | STIP1 | AMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRHD |
| P32969 | S135 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | RNFLGEKYIRRVRMRPGVACsVsQAQKDELILEGNDIELVS |
| P33993 | S314 | Sugiyama | MCM7 CDC47 MCM2 | SETyLEAHRIVKMNKSEDDEsGAGELtREELRQIAEEDFyE |
| P34897 | S417 | Sugiyama | SHMT2 | ERVLELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFR |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S415 | Sugiyama | HSPA4 APG2 HSPH2 | TDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTFy |
| P35222 | S45 | SIGNOR|ELM|iPTMNet|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | WQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQVLyE |
| P35579 | S169 | Sugiyama | MYH9 | HIyAITDtAyRSMMQDREDQsILCTGESGAGKTENTKKVIQ |
| P35580 | S1013 | Sugiyama | MYH10 | QNSKFIKEKKLMEDRIAECssQLAEEEEKAKNLAKIRNKQE |
| P35637 | S163 | PSP | FUS TLS | YGQQQSYNPPQGYGQQNQYNssSGGGGGGGGGGNYGQDQss |
| P35637 | S164 | PSP | FUS TLS | GQQQSYNPPQGYGQQNQYNssSGGGGGGGGGGNYGQDQssM |
| P35637 | S182 | PSP | FUS TLS | NssSGGGGGGGGGGNYGQDQssMSSGGGSGGGYGNQDQSGG |
| P35637 | S183 | PSP | FUS TLS | ssSGGGGGGGGGGNYGQDQssMSSGGGSGGGYGNQDQSGGG |
| P35637 | S221 | PSP | FUS TLS | GGGGSGGYGQQDRGGRGRGGsGGGGGGGGGGYNRSSGGYEP |
| P35637 | S273 | PSP | FUS TLS | GMGGsDRGGFNKFGGPRDQGsRHDsEQDNsDNNtIFVQGLG |
| P35637 | S277 | PSP | FUS TLS | sDRGGFNKFGGPRDQGsRHDsEQDNsDNNtIFVQGLGENVT |
| P35637 | S346 | PSP | FUS TLS | TDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFsGNPIKV |
| P35637 | S462 | PSP | FUS TLS | NECNQCKAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRG |
| P35637 | T338 | PSP | FUS TLS | GQPMINLyTDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKE |
| P35659 | S227 | Sugiyama | DEK | ERNsSGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDE |
| P36551 | S112 | Sugiyama | CPOX CPO CPX | AFGHVQRAEMLPKTSGTRAtsLGRPEEEEDELAHRCSSFMA |
| P36551 | T111 | Sugiyama | CPOX CPO CPX | AAFGHVQRAEMLPKTSGTRAtsLGRPEEEEDELAHRCSSFM |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37840 | S129 | iPTMNet | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40227 | T147 | Sugiyama | CCT6A CCT6 CCTZ | KEKALQFLEEVKVSREMDREtLIDVARTSLRTKVHAELADV |
| P40925 | S326 | Sugiyama | MDH1 MDHA | NDFSREKMDLTAKELtEEKEsAFEFLssA____________ |
| P40925 | S332 | Sugiyama | MDH1 MDHA | KMDLTAKELtEEKEsAFEFLssA__________________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43487 | S188 | Sugiyama | RANBP1 | KAGSGKNDHAEKVAEKLEALsVKEETKEDAEEKQ_______ |
| P43629 | S385 | SIGNOR|PSP | KIR3DL1 CD158E NKAT3 NKB1 | SNKKNAAVMDQEPAGNRTANsEDsDEQDPEEVTYAQLDHCV |
| P43629 | S388 | SIGNOR|PSP | KIR3DL1 CD158E NKAT3 NKB1 | KNAAVMDQEPAGNRTANsEDsDEQDPEEVTYAQLDHCVFTQ |
| P45973 | S13 | Sugiyama | CBX5 HP1A | ________MGKKTKRtADssssEDEEEyVVEKVLDRRVVKG |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46937 | S400 | SIGNOR | YAP1 YAP65 | NssDPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsV |
| P46937 | S403 | SIGNOR | YAP1 YAP65 | DPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEM |
| P47712 | S454 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | ssDsDDEsHEPKGtENEDAGsDyQsDNQASWIHRMIMALVS |
| P47756 | S204 | Sugiyama | CAPZB | sGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKI |
| P47756 | S207 | Sugiyama | CAPZB | MNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMENKIRst |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P48730 | S181 | Sugiyama | CSNK1D HCKID | tHQHIPYRENKNLtGtARYAsINtHLGIEQsRRDDLESLGY |
| P48730 | T184 | Sugiyama | CSNK1D HCKID | HIPYRENKNLtGtARYAsINtHLGIEQsRRDDLESLGYVLM |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49327 | S2198 | Sugiyama | FASN FAS | EVRQLTLRKLQELSSKADEAsELACPtPKEDGLAQQQtQLN |
| P49368 | S252 | Sugiyama | CCT3 CCTG TRIC5 | YIKNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEE |
| P49368 | T254 | Sugiyama | CCT3 CCTG TRIC5 | KNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEEEY |
| P49588 | S188 | Sugiyama | AARS1 AARS | PGNMKDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDD |
| P49674 | S181 | Sugiyama | CSNK1E | THQHIPYRENKNLTGTARYAsINtHLGIEQSRRDDLESLGY |
| P49674 | S323 | ELM | CSNK1E | DVDRERREHEREERMGQLRGsAtRALPPGPPtGAtANRLRs |
| P49674 | S368 | ELM | CSNK1E | VASTPAsRIQPAGNtsPRAIsRVDRERKVSMRLHRGAPANV |
| P49674 | S405 | ELM | CSNK1E | PANVsssDLTGRQEVSRIPAsQtsVPFDHLGK_________ |
| P49674 | S408 | ELM | CSNK1E | VsssDLTGRQEVSRIPAsQtsVPFDHLGK____________ |
| P49674 | T184 | Sugiyama | CSNK1E | HIPYRENKNLTGTARYAsINtHLGIEQSRRDDLESLGYVLM |
| P49674 | T325 | ELM | CSNK1E | DRERREHEREERMGQLRGsAtRALPPGPPtGAtANRLRsAA |
| P49674 | T334 | ELM | CSNK1E | EERMGQLRGsAtRALPPGPPtGAtANRLRsAAEPVASTPAs |
| P49674 | T337 | ELM | CSNK1E | MGQLRGsAtRALPPGPPtGAtANRLRsAAEPVASTPAsRIQ |
| P49674 | T407 | ELM | CSNK1E | NVsssDLTGRQEVSRIPAsQtsVPFDHLGK___________ |
| P49810 | S19 | SIGNOR|ELM|iPTMNet | PSEN2 AD4 PS2 PSNL2 STM2 | __MLTFMAsDsEEEVCDERtsLMsAEsPtPRSCQEGRQGPE |
| P49810 | S327 | SIGNOR|ELM|iPTMNet|PSP | PSEN2 AD4 PS2 PSNL2 STM2 | LDPSSQGALQLPYDPEMEEDsYDsFGEPsYPEVFEPPLTGY |
| P49810 | S330 | SIGNOR|ELM|iPTMNet|PSP | PSEN2 AD4 PS2 PSNL2 STM2 | SSQGALQLPYDPEMEEDsYDsFGEPsYPEVFEPPLTGYPGE |
| P49810 | S335 | SIGNOR|iPTMNet | PSEN2 AD4 PS2 PSNL2 STM2 | LQLPYDPEMEEDsYDsFGEPsYPEVFEPPLTGYPGEELEEE |
| P49810 | S7 | SIGNOR|ELM|iPTMNet | PSEN2 AD4 PS2 PSNL2 STM2 | ______________MLTFMAsDsEEEVCDERtsLMsAEsPt |
| P49810 | S9 | SIGNOR|ELM|iPTMNet | PSEN2 AD4 PS2 PSNL2 STM2 | ____________MLTFMAsDsEEEVCDERtsLMsAEsPtPR |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P50416 | S371 | Sugiyama | CPT1A CPT1 | GRLLKPREMEQQMQRILDNtsEPQPGEARLAALTAGDRVPW |
| P50502 | S76 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | KEEKPDSKKVEEDLKADEPssEEsDLEIDKEGVIEPDTDAP |
| P50502 | S79 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | KPDSKKVEEDLKADEPssEEsDLEIDKEGVIEPDTDAPQEM |
| P50993 | S215 | Sugiyama | ATP1A2 KIAA0778 | DRVPADLRIISSHGCKVDNssLtGESEPQTRSPEFTHENPL |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51532 | S31 | SIGNOR|PSP | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | tPRPGPSPGPGPSPGAMLGPsPGPsPGSAHSMMGPSPGPPS |
| P51532 | S35 | SIGNOR|PSP | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | GPSPGPGPSPGAMLGPsPGPsPGSAHSMMGPSPGPPSAGHP |
| P51532 | S699 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | PPTLPVEEKKKIPDPDsDDVsEVDARHIIENAKQDVDDEyG |
| P52597 | S107 | Sugiyama | HNRNPF HNRPF | KSHRTEMDWVLKHsGPNsADsANDGFVRLRGLPFGCTKEEI |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P53041 | T362 | SIGNOR|PSP | PPP5C PPP5 | QCINGKVLIMHGGLFSEDGVtLDDIRKIERNRQPPDSGPMC |
| P53618 | S474 | Sugiyama | COPB1 COPB MSTP026 | IYRGALWILGEYCSTKEDIQsVMtEIRRSLGEIPIVESEIK |
| P53618 | T477 | Sugiyama | COPB1 COPB MSTP026 | GALWILGEYCSTKEDIQsVMtEIRRSLGEIPIVESEIKKEA |
| P53985 | T231 | Sugiyama | SLC16A1 MCT1 | KAsLEKAGKSGVKKDLHDANtDLIGRHPKQEKRSVFQTINQ |
| P53999 | S19 | Sugiyama | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P54278 | S547 | Sugiyama | PMS2 PMSL2 | RGSQEHVDsQEKAPKTDDSFsDVDCHSNQEDTGCKFRVLPQ |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P54652 | S224 | Sugiyama | HSPA2 | GGGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P55072 | S37 | Sugiyama | VCP HEL-220 HEL-S-70 | LKQKNRPNRLIVDEAINEDNsVVsLSQPKMDELQLFRGDTV |
| P55072 | S40 | Sugiyama | VCP HEL-220 HEL-S-70 | KNRPNRLIVDEAINEDNsVVsLSQPKMDELQLFRGDTVLLK |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P55884 | S185 | Sugiyama | EIF3B EIF3S9 | EEELLGDVLKDRPQEADGIDsVIVVDNVPQVGPDRLEKLKN |
| P55957 | S64 | ELM | BID | LPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQEDIIR |
| P55957 | T59 | ELM | BID | ALGHELPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQ |
| P56817 | S498 | SIGNOR|ELM|PSP | BACE1 BACE KIAA1149 | CQWRCLRCLRQQHDDFADDIsLLK_________________ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61604 | S21 | Sugiyama | HSPE1 | MAGQAFRKFLPLFDRVLVERsAAETVTKGGIMLPEKSQGKV |
| P61916 | S29 | Sugiyama | NPC2 HE1 | LLLALSTAAQAEPVQFKDCGsVDGVIKEVNVsPCPtQPCQL |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S156 | Sugiyama | YWHAE | AtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLGLALN |
| P62258 | S210 | Sugiyama | YWHAE | RACRLAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtL |
| P62258 | T161 | Sugiyama | YWHAE | RKEAAENsLVAyKAAsDIAMtELPPTHPIRLGLALNFSVFY |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62495 | S295 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | LSNVKFIQEKKLIGRyFDEIsQDtGKyCFGVEDTLKALEMG |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62829 | S115 | Sugiyama | RPL23 | FLYFEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASN |
| P62829 | T118 | Sugiyama | RPL23 | FEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASNAGs |
| P62857 | S61 | Sugiyama | RPS28 | sIIRNVKGPVREGDVLtLLEsEREARRLR____________ |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | T55 | Sugiyama | RPS27A UBA80 UBCEP1 | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P62987 | T55 | Sugiyama | UBA52 UBCEP2 | GIPPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRG |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63151 | S409 | Sugiyama | PPP2R2A | RTVLKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKEN |
| P63151 | S412 | Sugiyama | PPP2R2A | LKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKENIIA |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P98082 | S193 | Sugiyama | DAB2 DOC2 | KKKEEEKKKIEEASKAVENGsEALMILDDQTNKLKSGVDQM |
| Q00535 | S159 | SIGNOR|ELM | CDK5 CDKN5 PSSALRE | ELKLADFGLARAFGIPVRCYsAEVVTLWYRPPDVLFGAKLY |
| Q00610 | S1494 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EEDyQALRTsIDAyDNFDNIsLAQRLEKHELIEFRRIAAYL |
| Q00987 | S118 | SIGNOR|PSP | MDM2 | KIYTMIYRNLVVVNQQESSDsGTsVSENRCHLEGGSDQKDL |
| Q00987 | S121 | SIGNOR|PSP | MDM2 | TMIYRNLVVVNQQESSDsGTsVSENRCHLEGGSDQKDLVQE |
| Q00987 | S166 | PSP | MDM2 | KPSSSHLVSRPstSSRRRAIsEtEENsDELsGERQRKRHKs |
| Q00987 | S172 | PSP | MDM2 | LVSRPstSSRRRAIsEtEENsDELsGERQRKRHKsDsISLs |
| Q00987 | S176 | PSP | MDM2 | PstSSRRRAIsEtEENsDELsGERQRKRHKsDsISLsFDES |
| Q00987 | S220 | PSP | MDM2 | CVIREICCERSSSSESTGtPsNPDLDAGVsEHSGDWLDQDs |
| Q00987 | S229 | PSP | MDM2 | RSSSSESTGtPsNPDLDAGVsEHSGDWLDQDsVsDQFsVEF |
| Q00987 | S240 | PSP | MDM2 | sNPDLDAGVsEHSGDWLDQDsVsDQFsVEFEVEsLDsEDYs |
| Q00987 | S246 | SIGNOR | MDM2 | AGVsEHSGDWLDQDsVsDQFsVEFEVEsLDsEDYsLsEEGQ |
| Q00987 | S253 | SIGNOR|PSP | MDM2 | GDWLDQDsVsDQFsVEFEVEsLDsEDYsLsEEGQELsDEDD |
| Q00987 | S260 | PSP | MDM2 | sVsDQFsVEFEVEsLDsEDYsLsEEGQELsDEDDEVyQVtV |
| Q00987 | S262 | SIGNOR|PSP | MDM2 | sDQFsVEFEVEsLDsEDYsLsEEGQELsDEDDEVyQVtVyQ |
| Q00987 | S269 | SIGNOR|PSP | MDM2 | FEVEsLDsEDYsLsEEGQELsDEDDEVyQVtVyQAGESDTD |
| Q00987 | S290 | PSP | MDM2 | DEDDEVyQVtVyQAGESDTDsFEEDPEISLADyWKCTSCNE |
| Q00987 | S342 | PSP | MDM2 | CWALRENWLPEDKGKDKGEIsEKAKLENstQAEEGFDVPDC |
| Q00987 | S350 | PSP | MDM2 | LPEDKGKDKGEIsEKAKLENstQAEEGFDVPDCKKtIVNDS |
| Q00987 | S373 | PSP | MDM2 | AEEGFDVPDCKKtIVNDSREsCVEENDDKITQAsQSQESED |
| Q00987 | S386 | PSP | MDM2 | IVNDSREsCVEENDDKITQAsQSQESEDysQPSTSsSIIyS |
| Q00987 | T279 | PSP | MDM2 | YsLsEEGQELsDEDDEVyQVtVyQAGESDTDsFEEDPEISL |
| Q00987 | T351 | PSP | MDM2 | PEDKGKDKGEIsEKAKLENstQAEEGFDVPDCKKtIVNDSR |
| Q00987 | T365 | PSP | MDM2 | AKLENstQAEEGFDVPDCKKtIVNDSREsCVEENDDKITQA |
| Q00987 | T419 | PSP | MDM2 | TSsSIIySsQEDVKEFEREEtQDKEEsVESsLPLNAIEPCV |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01650 | S35 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | AAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNITLLNG |
| Q02790 | T42 | Sugiyama | FKBP4 FKBP52 | GVDIsPKQDEGVLKVIKREGtGTEMPMIGDRVFVHYTGWLL |
| Q02880 | S1132 | SIGNOR | TOP2B | KEAQEKAAEEDETQNQHDDSsSDsGTPSGPDFNYILNMSLW |
| Q04637 | S1430 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GQDIGAFVAEQKVEyTLGEEsEAPGQRALPsEELNRQLEKL |
| Q04726 | S622 | Sugiyama | TLE3 KIAA1547 | VWDLHNQTLVRQFQGHTDGAsCIDISHDGTKLWTGGLDNTV |
| Q04760 | S114 | Sugiyama | GLO1 | SRKATLELTHNWGtEDDEtQsyHNGNsDPRGFGHIGIAVPD |
| Q04760 | S120 | Sugiyama | GLO1 | ELTHNWGtEDDEtQsyHNGNsDPRGFGHIGIAVPDVySACK |
| Q04917 | S25 | Sugiyama | YWHAH YWHA1 | EQLLQRARLAEQAERyDDMAsAMKAVtELNEPLsNEDRNLL |
| Q04917 | T31 | Sugiyama | YWHAH YWHA1 | ARLAEQAERyDDMAsAMKAVtELNEPLsNEDRNLLsVAyKN |
| Q05940 | S511 | ELM | SLC18A2 SVMT VMAT2 | KTKMYTQNNIQSYPIGEDEEsEsD_________________ |
| Q05940 | S513 | ELM | SLC18A2 SVMT VMAT2 | KMYTQNNIQSYPIGEDEEsEsD___________________ |
| Q07021 | S201 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | ALVLDCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKD |
| Q07021 | S205 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | DCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYT |
| Q08211 | S125 | Sugiyama | DHX9 DDX9 LKP NDH2 | LPttMGGPLPPHLALKAENNsEVGAsGyGVPGPTWDRGANL |
| Q12792 | T164 | Sugiyama | TWF1 PTK9 | PAPLtAAEEELRQIKINEVQtDVGVDTKHQtLQGVAFPISR |
| Q12906 | S190 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | HLTSPVVREEMEKVLAGEtLsVNDPPDVLDRQKCLAALASL |
| Q12906 | S46 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | EELEAVQNMVsHtERALKAVsDWIDEQEKGssEQAEsDNMD |
| Q12959 | S733 | Sugiyama | DLG1 | YTRPVIILGPMKDRINDDLIsEFPDKFGSCVPHTTRPKRDY |
| Q12968 | S207 | ELM | NFATC3 NFAT4 | HIYDDVDSELNEAAARFtLGsPLtsPGGsPGGCPGEETWHQ |
| Q12968 | S211 | ELM | NFATC3 NFAT4 | DVDSELNEAAARFtLGsPLtsPGGsPGGCPGEETWHQQYGL |
| Q12968 | S215 | ELM | NFATC3 NFAT4 | ELNEAAARFtLGsPLtsPGGsPGGCPGEETWHQQYGLGHSL |
| Q12968 | T204 | ELM | NFATC3 NFAT4 | sLsHIYDDVDSELNEAAARFtLGsPLtsPGGsPGGCPGEET |
| Q12968 | T210 | ELM | NFATC3 NFAT4 | DDVDSELNEAAARFtLGsPLtsPGGsPGGCPGEETWHQQYG |
| Q13148 | S292 | PSP | TARDBP TDP43 | RsGRFGGNPGGFGNQGGFGNsRGGGAGLGNNQGsNMGGGMN |
| Q13148 | S305 | PSP | TARDBP TDP43 | NQGGFGNsRGGGAGLGNNQGsNMGGGMNFGAFsINPAMMAA |
| Q13148 | S317 | PSP | TARDBP TDP43 | AGLGNNQGsNMGGGMNFGAFsINPAMMAAAQAALQSsWGMM |
| Q13148 | S333 | PSP | TARDBP TDP43 | FGAFsINPAMMAAAQAALQSsWGMMGMLAsQQNQsGPsGNN |
| Q13148 | S389 | PSP | TARDBP TDP43 | sGNNSYsGsNsGAAIGWGsAsNAGsGsGFNGGFGssMDsKs |
| Q13148 | S393 | PSP | TARDBP TDP43 | SYsGsNsGAAIGWGsAsNAGsGsGFNGGFGssMDsKssGWG |
| Q13148 | S395 | PSP | TARDBP TDP43 | sGsNsGAAIGWGsAsNAGsGsGFNGGFGssMDsKssGWGM_ |
| Q13148 | S403 | PSP | TARDBP TDP43 | IGWGsAsNAGsGsGFNGGFGssMDsKssGWGM_________ |
| Q13148 | S404 | PSP | TARDBP TDP43 | GWGsAsNAGsGsGFNGGFGssMDsKssGWGM__________ |
| Q13148 | S409 | PSP | TARDBP TDP43 | sNAGsGsGFNGGFGssMDsKssGWGM_______________ |
| Q13148 | S410 | PSP | TARDBP TDP43 | NAGsGsGFNGGFGssMDsKssGWGM________________ |
| Q13148 | S92 | PSP | TARDBP TDP43 | VYVVNYPKDNKRKMDEtDAssAVKVKRAVQKTSDLIVLGLP |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13428 | S341 | Sugiyama | TCOF1 | GKAGAVAsQTKAGKPEEDSEsSSEEssDsEEETPAAKALLQ |
| Q13547 | S85 | Sugiyama | HDAC1 RPD3L1 | TKYHSDDyIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDG |
| Q13610 | S59 | Sugiyama | PWP1 | AKEKLQEEGGGsDEEEtGsPsEDGMQsARTQARPREPLEDG |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14152 | T1031 | Sugiyama | EIF3A EIF3S10 KIAA0139 | HADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGPRRG |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14157 | S475 | Sugiyama | UBAP2L KIAA0144 NICE4 | PLPsKstsAPQMsPGssDNQsssPQPAQQKLKQQKKKAsLT |
| Q14203 | S417 | Sugiyama | DCTN1 | KKNQELEVVRQQRERLQEELsQAEstIDELKEQVDAALGAE |
| Q14203 | S421 | Sugiyama | DCTN1 | ELEVVRQQRERLQEELsQAEstIDELKEQVDAALGAEEMVE |
| Q14257 | S146 | Sugiyama | RCN2 ERC55 | MyDRVIDFDENtALDDAEEEsFRKLHLKDKKRFEKANQDSG |
| Q14257 | T137 | Sugiyama | RCN2 ERC55 | VTWDEyNIQMyDRVIDFDENtALDDAEEEsFRKLHLKDKKR |
| Q14444 | S97 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | DYQERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFM |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14511 | S780 | PSP | NEDD9 CASL | GDTLTRQVTAQDIRNKVMNSsNQLCEQLKTIVMATKMAALH |
| Q14511 | T804 | PSP | NEDD9 CASL | CEQLKTIVMATKMAALHYPStTALQEMVHQVTDLSRNAQLF |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14566 | S758 | Sugiyama | MCM6 | EDESALKRSELVNWYLKEIEsEIDsEEELINKKRIIEKVIH |
| Q14566 | T266 | Sugiyama | MCM6 | GTLIVVPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRA |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q15056 | S13 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | ________MADFDtyDDRAyssFGGGRGsRGsAGGHGsRSQ |
| Q15084 | S428 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | EREPWDGRDGELPVEDDIDLsDVELDDLGKDEL________ |
| Q15181 | S127 | Sugiyama | PPA1 IOPPP PP | NDKHTGCCGDNDPIDVCEIGsKVCARGEIIGVKVLGILAMI |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | S315 | Sugiyama | RCN1 RCN | NKDEKLTKEEILENWNMFVGsQAtNyGEDLtKNHDEL____ |
| Q15293 | T318 | Sugiyama | RCN1 RCN | EKLTKEEILENWNMFVGsQAtNyGEDLtKNHDEL_______ |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15642 | S504 | Sugiyama | TRIP10 CIP4 STOT STP | SRHARPPDPPAsAPPDsssNsAsQDtKESSEEPPSEESQDT |
| Q15700 | S699 | Sugiyama | DLG2 | YTRPVIILGPMKDRINDDLIsEFPDKFGSCVPHTTRPKRDY |
| Q15758 | S535 | Sugiyama | SLC1A5 ASCT2 M7V1 RDR RDRC | EEGNPLLKHyRGPAGDAtVAsEKEsVM______________ |
| Q15758 | S539 | Sugiyama | SLC1A5 ASCT2 M7V1 RDR RDRC | PLLKHyRGPAGDAtVAsEKEsVM__________________ |
| Q15758 | T532 | Sugiyama | SLC1A5 ASCT2 M7V1 RDR RDRC | VPTEEGNPLLKHyRGPAGDAtVAsEKEsVM___________ |
| Q16643 | S255 | Sugiyama | DBN1 D0S117E | HRRKQQTLEAEEAKRRLKEQsIFGDHRDEEEEtHMKKsEsE |
| Q16665 | S247 | SIGNOR|PSP | HIF1A BHLHE78 MOP1 PASD8 | IPHPSNIEIPLDSKTFLSRHsLDMKFSYCDERITELMGYEP |
| Q16822 | T109 | Sugiyama | PCK2 PEPCK2 | yNNCWLARTDPKDVARVESKtVIVTPSQRDTVPLPPGGARG |
| Q32P51 | S158 | Sugiyama | HNRNPA1L2 HNRNPA1L | TDRGsGKKRGFAFVTFDDHDsVDKIVIQKYHTVKGHNCEVR |
| Q4G0J3 | S261 | Sugiyama | LARP7 HDCMA18P | MDtsNtsIsKMKRsRPtsEGsDIEstEPQKQCSKKKKKRDR |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S405 | Sugiyama | HSP90AB3P HSP90BC | YMTEPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF7 | T410 | Sugiyama | HSP90AB3P HSP90BC | IDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEESK |
| Q58FF8 | S305 | Sugiyama | HSP90AB2P HSP90BB | RVVYMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKR |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q58FG1 | S251 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | EPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKKQEE |
| Q58FG1 | T248 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | YTIEPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKK |
| Q5H9R7 | S617 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | NIALFEACCKERIQQFDDGGsDEEDIWEEKHIAFtPEsQRR |
| Q5JTH9 | S66 | Sugiyama | RRP12 KIAA0690 | SGRSDLTVDAVKLHNELQsGsLRLGKsEAPEtPMEEEAELV |
| Q66LE6 | S415 | Sugiyama | PPP2R2D KIAA1541 | RASLKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDN |
| Q66LE6 | S418 | Sugiyama | PPP2R2D KIAA1541 | LKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDNVIA |
| Q68BL8 | T505 | Sugiyama | OLFML2B | DDIRNVIGRCKDTLSTITGPttQNtyGRNEGAWMKDPLAKD |
| Q68BL8 | T506 | Sugiyama | OLFML2B | DIRNVIGRCKDTLSTITGPttQNtyGRNEGAWMKDPLAKDE |
| Q68BL8 | T509 | Sugiyama | OLFML2B | NVIGRCKDTLSTITGPttQNtyGRNEGAWMKDPLAKDERIY |
| Q68BL8 | Y510 | Sugiyama | OLFML2B | VIGRCKDTLSTITGPttQNtyGRNEGAWMKDPLAKDERIYV |
| Q68D20 | S161 | Sugiyama | PMS2CL PMS2P13 | RGSQEHVDsQEKAPEtDDsFsDVDCHSNQEDTGCKFQVLPQ |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6NZY4 | T346 | Sugiyama | ZCCHC8 | AELENsGLALYDGKDGtDGEtEVGEIQQNKSVTYDLSKLVN |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PCE3 | S311 | Sugiyama | PGM2L1 BM32A | QKDPDPDFSTVKCPNPEEGEsVLELsLRLAEKENARVVLAT |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6U7Q0 | S396 | SIGNOR|PSP | ZNF322 ZNF322A ZNF388 ZNF489 | EKPFVCNVSEKGLELsPPHAsEAsQMS______________ |
| Q6ULP2 | S508 | Sugiyama | AFTPH AFTH | SCQEETILTKSDLKQTSDNLsEECQLARKSSGTGTEPVAKL |
| Q6UN15 | S87 | Sugiyama | FIP1L1 FIP1 RHE | EtAENGVPKPKVTETEDDsDsDsDDDEDDVHVTIGDIKTGA |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7KZ85 | S73 | Sugiyama | SUPT6H KIAA0162 SPT6H | NLKGFINDDDDEDEGEEDEGsDSGDsEDDVGHKKRKRtsFD |
| Q7KZ85 | S78 | Sugiyama | SUPT6H KIAA0162 SPT6H | INDDDDEDEGEEDEGsDSGDsEDDVGHKKRKRtsFDDRLED |
| Q7KZF4 | S473 | Sugiyama | SND1 TDRD11 | ALVSKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGL |
| Q7Z460 | S1216 | Sugiyama | CLASP1 KIAA0622 MAST1 | sQEDLNEPIKRDGKKECDIVsRDGGAAsPAtEGRGGsEVEG |
| Q7Z460 | S246 | Sugiyama | CLASP1 KIAA0622 MAST1 | VQKSGNMIQSANDKNFDDEDsVDGNRPssAsStSSKAPPSS |
| Q8IWX8 | S823 | Sugiyama | CHERP DAN26 SCAF6 | KSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEEN |
| Q8N392 | S209 | Sugiyama | ARHGAP18 | TEsQSLRTNENKYQGRDDEAsNLVGEEKLIPPEETPAPETD |
| Q8N6T3 | S270 | Sugiyama | ARFGAP1 ARF1GAP | NVLKPAQEKVKEGKIFDDVSsGVsQLAsKVQGVGSKGWRDV |
| Q8N6T3 | S273 | Sugiyama | ARFGAP1 ARF1GAP | KPAQEKVKEGKIFDDVSsGVsQLAsKVQGVGSKGWRDVttF |
| Q8N6T3 | S348 | Sugiyama | ARFGAP1 ARF1GAP | FWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWG |
| Q8N6T3 | T350 | Sugiyama | ARFGAP1 ARF1GAP | ETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWGSA |
| Q8NBJ7 | S283 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | GsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL__ |
| Q8NBS9 | S125 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KYNSMEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLFKPG |
| Q8NBS9 | S129 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | MEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLFKPGQEAV |
| Q8NHW5 | S304 | Sugiyama | RPLP0P6 | DTTAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TF05 | S57 | Sugiyama | PPP4R1 MEG1 PP4R1 | DFVSQDEMLTPLGRLDKyAAsENIFNRQMVARSLLDTLREV |
| Q8WU90 | S231 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | LPPGFVLKKDKKKEEKEDEIsLEDLIERERSALGPNVTKIT |
| Q8WU90 | S351 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLsEAs |
| Q8WU90 | S360 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | RDVDEtGItVAsLERFSTYTsDKDENKLsEAsGGRAENGER |
| Q8WU90 | T345 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DsVsVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDEN |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q8WWI1 | S709 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | VERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQKIKS |
| Q92598 | S852 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | NNFGAEPPHQNGECyPNEKNsVNMDLD______________ |
| Q92620 | S438 | Sugiyama | DHX38 DDX38 KIAA0224 PRP16 | DGRIVFTKQPEPVIPVKDATsDLAIIARKGSQTVRKHREQK |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q92769 | S424 | Sugiyama | HDAC2 | KRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGAKK |
| Q92769 | S86 | Sugiyama | HDAC2 | TKYHSDEYIKFLRSIRPDNMsEysKQMQRFNVGEDCPVFDG |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q92973 | T335 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | GMKySDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQ |
| Q93062 | S14 | Sugiyama | RBPMS HERMES | _______MNNGGKAEKENtPsEANLQEEEVRTLFVSGLPLD |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96FS4 | S55 | Sugiyama | SIPA1 SPA1 | PLTPHTFEPRPVRGPLLRsGsDAGEARPPtPAsPRARAHsH |
| Q96G46 | T57 | Sugiyama | DUS3L | TKEQFHQFLEAKGQEKtCREtEVGDPAGNELAEPEAKRIRL |
| Q96GM8 | S420 | Sugiyama | TOE1 | KNDLEMGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRA |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | S145 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | NNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNF |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96KB5 | S298 | Sugiyama | PBK TOPK | RPPINMEELDESYQKVIELFsVCtNEDPKDRPsAAHIVEAL |
| Q96KB5 | T301 | Sugiyama | PBK TOPK | INMEELDESYQKVIELFsVCtNEDPKDRPsAAHIVEALEtD |
| Q96RE7 | S175 | Sugiyama | NACC1 BTBD14B NAC1 | ACSTPLPLVSRVKTEQQESDsVQCMPVAKRLWDsGQKEAGG |
| Q96S66 | S59 | Sugiyama | CLCC1 KIAA0761 MCLC | MRKSQAKYGISGEKDVSPDLsCADEIsECyHKLDSLTYKID |
| Q96S66 | Y68 | Sugiyama | CLCC1 KIAA0761 MCLC | ISGEKDVSPDLsCADEIsECyHKLDSLTYKIDECEKKKRED |
| Q96SB4 | S334 | Sugiyama | SRPK1 | ERPLKENPPNKMtQEKLEEsstIGQDQtLMERDTEGGAAEI |
| Q96T88 | S95 | SIGNOR|PSP | UHRF1 ICBP90 NP95 RNF106 | QsLVLPHSTKERDsELsDtDsGCCLGQSESDKsstHGEAAA |
| Q99439 | S217 | Sugiyama | CNN2 | ILPPMDHSTISLQMGTNKCAsQVGMTAPGTRRHIyDTKLGT |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99613 | S15 | Sugiyama | EIF3C EIF3S8 | ______MSRFFttGsDsEsEssLsGEELVTKPVGGNyGKQP |
| Q99613 | S16 | Sugiyama | EIF3C EIF3S8 | _____MSRFFttGsDsEsEssLsGEELVTKPVGGNyGKQPL |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99733 | S121 | Sugiyama | NAP1L4 NAP2 | PLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKV |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q99814 | S383 | PSP | EPAS1 BHLHE73 HIF2A MOP2 PASD2 | FKPHLMAMNSIFDSSGKGAVsEKSNFLFTKLKEEPEELAQL |
| Q99814 | T528 | PSP | EPAS1 BHLHE73 HIF2A MOP2 PASD2 | DTEAKDQCSTQTDFNELDLEtLAPYIPMDGEDFQLSPICPE |
| Q99848 | S269 | Sugiyama | EBNA1BP2 EBP2 | GFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGS |
| Q99961 | S108 | Sugiyama | SH3GL1 CNSA1 SH3D2B | QSEGLLGECMIRHGKELGGEsNFGDALLDAGEsMKRLAEVK |
| Q9BQ52 | S215 | Sugiyama | ELAC2 HPC2 | QPWQsPERPLsRLsPERssDsEsNENEPHLPHGVsQRRGVR |
| Q9BQ52 | S217 | Sugiyama | ELAC2 HPC2 | WQsPERPLsRLsPERssDsEsNENEPHLPHGVsQRRGVRDs |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BQK8 | S262 | Sugiyama | LPIN3 LIPN3L | SHMQWAWGRLPKVARAERPEsSVVLEGRAGATSPPRGGPST |
| Q9BRK4 | S220 | PSP | LZTS2 KIAA1813 LAPSER1 | DKPLAFSGWASGCPSGTLSDsGRNsLssLPTYSTGGAEPtt |
| Q9BRK4 | S224 | PSP | LZTS2 KIAA1813 LAPSER1 | AFSGWASGCPSGTLSDsGRNsLssLPTYSTGGAEPttssPG |
| Q9BRK4 | S273 | PSP | LZTS2 KIAA1813 LAPSER1 | GRGALPGPARGVPTGPSHSDsGRssSsKSTGSLGGRVAGGL |
| Q9BRK4 | S277 | PSP | LZTS2 KIAA1813 LAPSER1 | LPGPARGVPTGPSHSDsGRssSsKSTGSLGGRVAGGLLGsG |
| Q9BWU0 | S709 | Sugiyama | SLC4A1AP HLC3 | SRGELKKKKTPGPGKLPPTLsSKYPEDDPDYCVWVPPEGQS |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZL6 | S244 | PSP | PRKD2 PKD2 HSPC187 | RsttELLPRRPPsssssssAssYTGRPIELDKMLLSKVKVP |
| Q9C0C2 | S1174 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ttAGsVDWTDQLGLRNLEVssCVGsGGssEAREsAVGQMGW |
| Q9C0C2 | S1331 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | WGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMDWTQDLAPQ |
| Q9GZV5 | S314 | SIGNOR | WWTR1 TAZ | NssDPFLNGGPyHsREQsTDsGLGLGCySVPTtPEDFLSNV |
| Q9H1E3 | S144 | Sugiyama | NUCKS1 NUCKS JC7 | PFQEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPER |
| Q9H1I8 | S549 | Sugiyama | ASCC2 ASC1P100 RQT3 | PTPLLTSRHNVFQNDEFDVFsRDsVDLSRVHKGKSTRKEEN |
| Q9H1I8 | S552 | Sugiyama | ASCC2 ASC1P100 RQT3 | LLTSRHNVFQNDEFDVFsRDsVDLSRVHKGKSTRKEENTRS |
| Q9H2U2 | S309 | Sugiyama | PPA2 HSPC124 | NCTNVQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVW |
| Q9H2U2 | S313 | Sugiyama | PPA2 HSPC124 | VQISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLG |
| Q9H2U2 | S315 | Sugiyama | PPA2 HSPC124 | ISDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK_ |
| Q9H3P7 | S393 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | SMWTRPQIKDFKEKIQQDADsVItVGRGEVVTVRVPTHEEG |
| Q9H3P7 | T396 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | TRPQIKDFKEKIQQDADsVItVGRGEVVTVRVPTHEEGSYL |
| Q9H6Z4 | S355 | Sugiyama | RANBP3 | PKLNEVssDANRENAAAEsGsEsssQEAtPEKESLAEsAAA |
| Q9H6Z4 | S357 | Sugiyama | RANBP3 | LNEVssDANRENAAAEsGsEsssQEAtPEKESLAEsAAAyT |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NR28 | Y235 | Sugiyama | DIABLO SMAC | ELRQKTQEEGEERAEsEQEAyLRED________________ |
| Q9NR30 | S466 | Sugiyama | DDX21 | ETKKEAQELSQNsAIKQDAQsLHGDIPQKQREITLKGFRNG |
| Q9NTJ3 | S27 | Sugiyama | SMC4 CAPC SMC4L1 | QPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsPAtAAE |
| Q9NUQ3 | S86 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | HQGSNCGGTSNKHSLEEDEGsDFItENRNLVsPAyCtQEsR |
| Q9NW13 | S200 | Sugiyama | RBM28 | KGRTVAVDWAVAKDKYKDTQsVsAIGEEKSHESKHQESVKK |
| Q9NW13 | S202 | Sugiyama | RBM28 | RTVAVDWAVAKDKYKDTQsVsAIGEEKSHESKHQESVKKKG |
| Q9NYL9 | S25 | Sugiyama | TMOD3 | FRKDLEKyKDLDEDELLGNLsEtELKQLETVLDDLDPENAL |
| Q9NZL9 | S110 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | IVHCAAERRPDVVENQPDAAsQLNVDASGNLAKEAAAVGAF |
| Q9P2I0 | S419 | Sugiyama | CPSF2 CPSF100 KIAA1367 | EKLKKEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKH |
| Q9P2I0 | S420 | Sugiyama | CPSF2 CPSF100 KIAA1367 | KLKKEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKHD |
| Q9P2I0 | S423 | Sugiyama | CPSF2 CPSF100 KIAA1367 | KEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKHDLMM |
| Q9UBU9 | S62 | Sugiyama | NXF1 TAP | RGGSGIRSSRLEEDDGDVAMsDAQDGPRVRYNPYTTRPNRR |
| Q9UHD8 | S247 | Sugiyama | SEPTIN9 KIAA0991 MSF SEPT9 | PQPPVAEAtPRsQEATEAAPsCVGDMADtPRDAGLKQAPAS |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9Y266 | S285 | Sugiyama | NUDC | NtKKINPENsKLsDLDsEtRsMVEKMMYDQRQKsMGLPtsD |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2X7 | S385 | Sugiyama | GIT1 | DNLELsLRSQSDLDDQHDyDsVAsDEDtDQEPLRSTGATRS |
| Q9Y2X7 | S388 | Sugiyama | GIT1 | ELsLRSQSDLDDQHDyDsVAsDEDtDQEPLRSTGATRSNRA |
| Q9Y383 | S347 | Sugiyama | LUC7L2 CGI-59 CGI-74 | SRERSKRRSSKERFRDQDLAsCDRDRssRDRSPRDRDRKDK |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3B9 | S266 | Sugiyama | RRP15 KIAA0507 CGI-115 | WTILRDDFMMGAsMKDWDKEsDGPDDSRPEsAsDsDt____ |
| Q9Y3B9 | S67 | Sugiyama | RRP15 KIAA0507 CGI-115 | GSCGsEKDHFYsDDDAIEADsEGDAEPCDKENENDGEssVG |
| Q9Y450 | S64 | Sugiyama | HBS1L HBS1 KIAA1038 | RRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsC |
| Q9Y4K0 | S411 | Sugiyama | LOXL2 | NEIQCTGNEKSIIDCKFNAEsQGCNHEEDAGVRCNTPAMGL |
| Q9Y5J1 | S210 | Sugiyama | UTP18 WDR50 CDABP0061 CGI-48 | MGGVPAWAETTKRKtssDDEsEEDEDDLLQRTGNFISTsTS |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y696 | S236 | Sugiyama | CLIC4 | GIWRYLtNAysRDEFtNtCPsDKEVEIAysDVAKRLTK___ |
| Q9Y696 | S245 | Sugiyama | CLIC4 | ysRDEFtNtCPsDKEVEIAysDVAKRLTK____________ |
| Q9Y696 | S27 | Sugiyama | CLIC4 | LNGLKEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWL |
| Q9Y696 | S31 | Sugiyama | CLIC4 | KEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWLKGVV |
| Q9Y6A5 | S583 | Sugiyama | TACC3 ERIC1 | FDPLLRDsPGRPVPVATEtssMHGANEtPSGRPREAKLVEF |
| Q9Y6Q9 | S601 | SIGNOR|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | EssMCQsNsRDHLSDKESKEsSVEGAENQRGPLESKGHKKL |
| Q9Y6W5 | S474 | Sugiyama | WASF2 WAVE2 | EEQREQEKRDVVGNDVAtILsRRIAVEYsDsEDDssEFDED |
| Q9Y6W5 | T471 | Sugiyama | WASF2 WAVE2 | RRVEEQREQEKRDVVGNDVAtILsRRIAVEYsDsEDDssEF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Mitotic Prometaphase | R-HSA-68877 | 1.198106e-09 | 8.922 | 1 | 0 |
| M Phase | R-HSA-68886 | 1.718515e-08 | 7.765 | 1 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.006284e-08 | 7.522 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.586208e-08 | 7.339 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.182307e-07 | 6.927 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.784538e-07 | 6.748 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.239301e-07 | 6.205 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.211132e-07 | 6.142 | 1 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.580252e-06 | 5.588 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.870440e-06 | 5.542 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.243721e-06 | 5.084 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.169128e-05 | 4.932 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.161162e-05 | 4.935 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.334908e-05 | 4.632 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.973638e-05 | 4.527 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.555927e-05 | 4.449 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.578975e-05 | 4.253 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.488478e-05 | 4.261 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.488478e-05 | 4.261 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.267246e-05 | 4.203 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.422562e-05 | 4.192 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.239894e-05 | 4.084 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.218124e-05 | 4.085 | 1 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.104008e-04 | 3.957 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.210161e-04 | 3.917 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.170799e-04 | 3.932 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.203857e-04 | 3.919 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.324310e-04 | 3.878 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.357071e-04 | 3.867 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.552879e-04 | 3.809 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.552879e-04 | 3.809 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.648865e-04 | 3.783 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.685374e-04 | 3.773 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.922592e-04 | 3.716 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.930269e-04 | 3.714 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.064115e-04 | 3.685 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.179157e-04 | 3.662 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.219854e-04 | 3.654 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.270930e-04 | 3.644 | 1 | 1 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.492119e-04 | 3.603 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.407802e-04 | 3.618 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.556099e-04 | 3.592 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.119514e-04 | 3.506 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.140974e-04 | 3.503 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.730779e-04 | 3.428 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.836224e-04 | 3.416 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.875886e-04 | 3.412 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.563457e-04 | 3.341 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.546845e-04 | 3.342 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.924703e-04 | 3.227 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.020956e-04 | 3.220 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.581930e-04 | 3.182 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.134053e-04 | 3.147 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.774626e-04 | 3.109 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.419271e-04 | 3.075 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.154385e-04 | 3.038 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.044089e-03 | 2.981 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.994711e-04 | 3.000 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.058803e-03 | 2.975 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.109033e-03 | 2.955 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.135536e-03 | 2.945 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.210387e-03 | 2.917 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.189833e-03 | 2.925 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.212860e-03 | 2.916 | 1 | 1 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.241947e-03 | 2.906 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.337554e-03 | 2.874 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.273889e-03 | 2.895 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.273889e-03 | 2.895 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.478217e-03 | 2.830 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.602065e-03 | 2.795 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.748753e-03 | 2.757 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.748753e-03 | 2.757 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.861302e-03 | 2.730 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.170719e-03 | 2.663 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.170719e-03 | 2.663 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.100360e-03 | 2.678 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.061152e-03 | 2.686 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.108008e-03 | 2.676 | 1 | 1 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.108008e-03 | 2.676 | 1 | 1 |
| EGFR downregulation | R-HSA-182971 | 2.046109e-03 | 2.689 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.141009e-03 | 2.669 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.130303e-03 | 2.672 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.100360e-03 | 2.678 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.100360e-03 | 2.678 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.726452e-03 | 2.564 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.810369e-03 | 2.551 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.819971e-03 | 2.550 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.940332e-03 | 2.532 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.966398e-03 | 2.528 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.204456e-03 | 2.494 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.204456e-03 | 2.494 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.049739e-03 | 2.516 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.220039e-03 | 2.492 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.253841e-03 | 2.488 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.253841e-03 | 2.488 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.642621e-03 | 2.439 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.731936e-03 | 2.428 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.958090e-03 | 2.403 | 1 | 1 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.128403e-03 | 2.384 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.897730e-03 | 2.409 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.286860e-03 | 2.368 | 1 | 1 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.665483e-03 | 2.331 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.679996e-03 | 2.330 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.679996e-03 | 2.330 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.753299e-03 | 2.323 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.755566e-03 | 2.323 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.937646e-03 | 2.306 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.143852e-03 | 2.289 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.332297e-03 | 2.273 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.936212e-03 | 2.226 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.882409e-03 | 2.230 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.965304e-03 | 2.224 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.501906e-03 | 2.187 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.501906e-03 | 2.187 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.869446e-03 | 2.163 | 1 | 1 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.986351e-03 | 2.156 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.070092e-03 | 2.151 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.563066e-03 | 2.121 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.563066e-03 | 2.121 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.626268e-03 | 2.118 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.626268e-03 | 2.118 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.626268e-03 | 2.118 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.453091e-03 | 2.073 | 1 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.304429e-03 | 2.081 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.989380e-03 | 2.046 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.441185e-03 | 2.025 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.020529e-02 | 1.991 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.058437e-02 | 1.975 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.126697e-02 | 1.948 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.126697e-02 | 1.948 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.126697e-02 | 1.948 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.222161e-02 | 1.913 | 1 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.269594e-02 | 1.896 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.269594e-02 | 1.896 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.243548e-02 | 1.905 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.346008e-02 | 1.871 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.294312e-02 | 1.888 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.372253e-02 | 1.863 | 1 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.236604e-02 | 1.908 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.375447e-02 | 1.862 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.392349e-02 | 1.856 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.392349e-02 | 1.856 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.392349e-02 | 1.856 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.392349e-02 | 1.856 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.392349e-02 | 1.856 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.538502e-02 | 1.813 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.682136e-02 | 1.774 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.682136e-02 | 1.774 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.691496e-02 | 1.772 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.839989e-02 | 1.735 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.049760e-02 | 1.688 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.116074e-02 | 1.674 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.427817e-02 | 1.615 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.427817e-02 | 1.615 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.427817e-02 | 1.615 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.283963e-02 | 1.641 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.427817e-02 | 1.615 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.205676e-02 | 1.656 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.297176e-02 | 1.639 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.336343e-02 | 1.631 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.336343e-02 | 1.631 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.427817e-02 | 1.615 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.466407e-02 | 1.608 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.504924e-02 | 1.601 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.504924e-02 | 1.601 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.539604e-02 | 1.595 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.559443e-02 | 1.592 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.644002e-02 | 1.578 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.812806e-02 | 1.551 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.078917e-02 | 1.512 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.947535e-02 | 1.531 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.956789e-02 | 1.529 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.956674e-02 | 1.529 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.907770e-02 | 1.536 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.181628e-02 | 1.497 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.959751e-02 | 1.529 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.934257e-02 | 1.533 | 1 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.084664e-02 | 1.511 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.792507e-02 | 1.554 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.990213e-02 | 1.524 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.974546e-02 | 1.527 | 1 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.204707e-02 | 1.494 | 1 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.217263e-02 | 1.493 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.217263e-02 | 1.493 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.451542e-02 | 1.462 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.490224e-02 | 1.457 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.507539e-02 | 1.455 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.507539e-02 | 1.455 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.582169e-02 | 1.446 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.910390e-02 | 1.408 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.957027e-02 | 1.403 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.041112e-02 | 1.393 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.963422e-02 | 1.304 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.963422e-02 | 1.304 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.963422e-02 | 1.304 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.963422e-02 | 1.304 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.963422e-02 | 1.304 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.686331e-02 | 1.329 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.579737e-02 | 1.339 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.644053e-02 | 1.333 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.482140e-02 | 1.349 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.864081e-02 | 1.313 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.487853e-02 | 1.348 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.963422e-02 | 1.304 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.811969e-02 | 1.318 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.487853e-02 | 1.348 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.299678e-02 | 1.367 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.579737e-02 | 1.339 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.655268e-02 | 1.332 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.286141e-02 | 1.277 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.299913e-02 | 1.276 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.507020e-02 | 1.259 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.544257e-02 | 1.256 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.544257e-02 | 1.256 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.594182e-02 | 1.252 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.739854e-02 | 1.241 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.609356e-02 | 1.180 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.419172e-02 | 1.193 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.949535e-02 | 1.226 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.136281e-02 | 1.212 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.772292e-02 | 1.169 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.009245e-02 | 1.221 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.136281e-02 | 1.212 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.638931e-02 | 1.178 | 1 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.304218e-02 | 1.200 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.832055e-02 | 1.234 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.697343e-02 | 1.174 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.009245e-02 | 1.221 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.185102e-02 | 1.209 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.136281e-02 | 1.212 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.136281e-02 | 1.212 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.046689e-02 | 1.218 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.034218e-02 | 1.219 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.609356e-02 | 1.180 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.895095e-02 | 1.161 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.489689e-02 | 1.188 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.761994e-02 | 1.170 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.963585e-02 | 1.157 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.232409e-02 | 1.205 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.136281e-02 | 1.212 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.014412e-02 | 1.221 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.136281e-02 | 1.212 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.059431e-02 | 1.151 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.282255e-02 | 1.138 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 7.326231e-02 | 1.135 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.326231e-02 | 1.135 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 7.326231e-02 | 1.135 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.340325e-02 | 1.134 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.368378e-02 | 1.133 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.368378e-02 | 1.133 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.368378e-02 | 1.133 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.541523e-02 | 1.123 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.588992e-02 | 1.120 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.772616e-02 | 1.109 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.772616e-02 | 1.109 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.772616e-02 | 1.109 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.434596e-02 | 1.074 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 8.469284e-02 | 1.072 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.469284e-02 | 1.072 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.503680e-02 | 1.070 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.530917e-02 | 1.069 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.534318e-02 | 1.069 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.734489e-02 | 1.059 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.020072e-02 | 1.045 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.059946e-02 | 1.043 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.110339e-02 | 1.040 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.122918e-02 | 1.040 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 9.970576e-02 | 1.001 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.970576e-02 | 1.001 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 9.970576e-02 | 1.001 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 9.970576e-02 | 1.001 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.196680e-02 | 1.036 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.196680e-02 | 1.036 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.196680e-02 | 1.036 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.196680e-02 | 1.036 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.035598e-01 | 0.985 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.138089e-01 | 0.944 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.098682e-01 | 0.959 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.035598e-01 | 0.985 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.037939e-01 | 0.984 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.138089e-01 | 0.944 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.971592e-02 | 1.001 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.057725e-01 | 0.976 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.043082e-01 | 0.982 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.037939e-01 | 0.984 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.381623e-02 | 1.028 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.357162e-02 | 1.029 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.357162e-02 | 1.029 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.064092e-01 | 0.973 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.333906e-02 | 1.030 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.041926e-01 | 0.982 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 9.381623e-02 | 1.028 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.750169e-02 | 1.011 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.142764e-01 | 0.942 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.960906e-02 | 1.002 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.037206e-01 | 0.984 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.037939e-01 | 0.984 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.173339e-01 | 0.931 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.176735e-01 | 0.929 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.176735e-01 | 0.929 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.178690e-01 | 0.929 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.178690e-01 | 0.929 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.181389e-01 | 0.928 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.181389e-01 | 0.928 | 1 | 1 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.181389e-01 | 0.928 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.185307e-01 | 0.926 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.195045e-01 | 0.923 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.221970e-01 | 0.913 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.228529e-01 | 0.911 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.245492e-01 | 0.905 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.267192e-01 | 0.897 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.276062e-01 | 0.894 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.622174e-01 | 0.790 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.283189e-01 | 0.892 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.283189e-01 | 0.892 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.283189e-01 | 0.892 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 1.585452e-01 | 0.800 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 1.585452e-01 | 0.800 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.585452e-01 | 0.800 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.289824e-01 | 0.889 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.289824e-01 | 0.889 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.289824e-01 | 0.889 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.289824e-01 | 0.889 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.491683e-01 | 0.826 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.491683e-01 | 0.826 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.491683e-01 | 0.826 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.702834e-01 | 0.769 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.702834e-01 | 0.769 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.702834e-01 | 0.769 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.702834e-01 | 0.769 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.702834e-01 | 0.769 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.702834e-01 | 0.769 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.702834e-01 | 0.769 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.702834e-01 | 0.769 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.702834e-01 | 0.769 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.332877e-01 | 0.875 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.491817e-01 | 0.826 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.302547e-01 | 0.885 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.474354e-01 | 0.831 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.595425e-01 | 0.797 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.672698e-01 | 0.777 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.672698e-01 | 0.777 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.634645e-01 | 0.787 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.630142e-01 | 0.788 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.618866e-01 | 0.791 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.357642e-01 | 0.867 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.482404e-01 | 0.829 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.302547e-01 | 0.885 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.702834e-01 | 0.769 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.541400e-01 | 0.812 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.302547e-01 | 0.885 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.302547e-01 | 0.885 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.491817e-01 | 0.826 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.289824e-01 | 0.889 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.376484e-01 | 0.861 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.702834e-01 | 0.769 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.434150e-01 | 0.843 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.283189e-01 | 0.892 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.657588e-01 | 0.781 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.585452e-01 | 0.800 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.571217e-01 | 0.804 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.622174e-01 | 0.790 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.491683e-01 | 0.826 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.491683e-01 | 0.826 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.289824e-01 | 0.889 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.377341e-01 | 0.861 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.585452e-01 | 0.800 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.634645e-01 | 0.787 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.702834e-01 | 0.769 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.357642e-01 | 0.867 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.402602e-01 | 0.853 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.434150e-01 | 0.843 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.347421e-01 | 0.870 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.491817e-01 | 0.826 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.701178e-01 | 0.769 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.422882e-01 | 0.847 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.713401e-01 | 0.766 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.713401e-01 | 0.766 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.777440e-01 | 0.750 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.777440e-01 | 0.750 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.829547e-01 | 0.738 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.829547e-01 | 0.738 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.331800e-01 | 0.632 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.331800e-01 | 0.632 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.331800e-01 | 0.632 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.331800e-01 | 0.632 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.331800e-01 | 0.632 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.981358e-01 | 0.526 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.981358e-01 | 0.526 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 2.981358e-01 | 0.526 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.981358e-01 | 0.526 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.981358e-01 | 0.526 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.981358e-01 | 0.526 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.899067e-01 | 0.721 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.899067e-01 | 0.721 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.899067e-01 | 0.721 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 1.899067e-01 | 0.721 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.219945e-01 | 0.654 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.219945e-01 | 0.654 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.219945e-01 | 0.654 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 2.219945e-01 | 0.654 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.219945e-01 | 0.654 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.575928e-01 | 0.447 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.575928e-01 | 0.447 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.575928e-01 | 0.447 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.544611e-01 | 0.594 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.544611e-01 | 0.594 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.921871e-01 | 0.716 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.921871e-01 | 0.716 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.147420e-01 | 0.668 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.870123e-01 | 0.542 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.870123e-01 | 0.542 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.120162e-01 | 0.385 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.120162e-01 | 0.385 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.120162e-01 | 0.385 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.120162e-01 | 0.385 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.378160e-01 | 0.624 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.378160e-01 | 0.624 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.378160e-01 | 0.624 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.194012e-01 | 0.496 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.194012e-01 | 0.496 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.612830e-01 | 0.583 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.612830e-01 | 0.583 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.612830e-01 | 0.583 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.860335e-01 | 0.730 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.860335e-01 | 0.730 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.011636e-01 | 0.696 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.514217e-01 | 0.454 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.514217e-01 | 0.454 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.618320e-01 | 0.336 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 4.618320e-01 | 0.336 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.618320e-01 | 0.336 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.618320e-01 | 0.336 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.758951e-01 | 0.559 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.758951e-01 | 0.559 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.829041e-01 | 0.417 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 3.829041e-01 | 0.417 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.829041e-01 | 0.417 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.328935e-01 | 0.478 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.328935e-01 | 0.478 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.954160e-01 | 0.530 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.400148e-01 | 0.620 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.183782e-01 | 0.661 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.568235e-01 | 0.448 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.568235e-01 | 0.448 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.137099e-01 | 0.383 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.074299e-01 | 0.295 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.074299e-01 | 0.295 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.074299e-01 | 0.295 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.074299e-01 | 0.295 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.074299e-01 | 0.295 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.074299e-01 | 0.295 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.074299e-01 | 0.295 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.074299e-01 | 0.295 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.074299e-01 | 0.295 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.988723e-01 | 0.525 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.348918e-01 | 0.475 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.348918e-01 | 0.475 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.806322e-01 | 0.419 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.806322e-01 | 0.419 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.806322e-01 | 0.419 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.806322e-01 | 0.419 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.806322e-01 | 0.419 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.437279e-01 | 0.353 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.437279e-01 | 0.353 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.259256e-01 | 0.646 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.745683e-01 | 0.426 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.943510e-01 | 0.404 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.943510e-01 | 0.404 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.728704e-01 | 0.325 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.728704e-01 | 0.325 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.728704e-01 | 0.325 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.491669e-01 | 0.260 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.491669e-01 | 0.260 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.491669e-01 | 0.260 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.491669e-01 | 0.260 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.491669e-01 | 0.260 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.491669e-01 | 0.260 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.505866e-01 | 0.346 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.022713e-01 | 0.395 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.010705e-01 | 0.300 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.010705e-01 | 0.300 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.010705e-01 | 0.300 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.010705e-01 | 0.300 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.530985e-01 | 0.452 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.732048e-01 | 0.325 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.732048e-01 | 0.325 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 5.282786e-01 | 0.277 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 5.282786e-01 | 0.277 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.170903e-01 | 0.286 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.544604e-01 | 0.256 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.544604e-01 | 0.256 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.037735e-01 | 0.298 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.037735e-01 | 0.298 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.277967e-01 | 0.278 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.858447e-01 | 0.314 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.200801e-01 | 0.284 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.286616e-01 | 0.277 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.286616e-01 | 0.277 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.144149e-01 | 0.289 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.172206e-01 | 0.286 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.088988e-01 | 0.293 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.095213e-01 | 0.293 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.978397e-01 | 0.704 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.278874e-01 | 0.369 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.400148e-01 | 0.620 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.400148e-01 | 0.620 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.989346e-01 | 0.701 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.704699e-01 | 0.568 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.189381e-01 | 0.660 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.487764e-01 | 0.604 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.538570e-01 | 0.451 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.169207e-01 | 0.380 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.083458e-01 | 0.511 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.909319e-01 | 0.309 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.978494e-01 | 0.526 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.692794e-01 | 0.570 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.297556e-01 | 0.482 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.194012e-01 | 0.496 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.194012e-01 | 0.496 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.758951e-01 | 0.559 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.572141e-01 | 0.590 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.328935e-01 | 0.478 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.568235e-01 | 0.448 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.544604e-01 | 0.256 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.219945e-01 | 0.654 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 2.870123e-01 | 0.542 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.870123e-01 | 0.542 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.194012e-01 | 0.496 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 3.514217e-01 | 0.454 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.335712e-01 | 0.363 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.909319e-01 | 0.309 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.612830e-01 | 0.583 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.612830e-01 | 0.583 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.277967e-01 | 0.278 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.959439e-01 | 0.708 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.277967e-01 | 0.278 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.219945e-01 | 0.654 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.120162e-01 | 0.385 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.618320e-01 | 0.336 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.137099e-01 | 0.383 | 1 | 1 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.137099e-01 | 0.383 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.070260e-01 | 0.684 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.151012e-01 | 0.502 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.657511e-01 | 0.332 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.390152e-01 | 0.622 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.089289e-01 | 0.510 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.829041e-01 | 0.417 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.482318e-01 | 0.261 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.196047e-01 | 0.658 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.720560e-01 | 0.326 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.487764e-01 | 0.604 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.378160e-01 | 0.624 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.514217e-01 | 0.454 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.618320e-01 | 0.336 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.618320e-01 | 0.336 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.829041e-01 | 0.417 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.829041e-01 | 0.417 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.328935e-01 | 0.478 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.568235e-01 | 0.448 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.042413e-01 | 0.393 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.943510e-01 | 0.404 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.529245e-01 | 0.344 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.529245e-01 | 0.344 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.544604e-01 | 0.256 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.544604e-01 | 0.256 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.049677e-01 | 0.297 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.514109e-01 | 0.600 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.943510e-01 | 0.404 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.603563e-01 | 0.443 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.612830e-01 | 0.583 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.093266e-01 | 0.679 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.343700e-01 | 0.476 | 1 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.852756e-01 | 0.545 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.538570e-01 | 0.451 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.991825e-01 | 0.524 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.382804e-01 | 0.269 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.375921e-01 | 0.624 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.194012e-01 | 0.496 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.348918e-01 | 0.475 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.460029e-01 | 0.609 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.275803e-01 | 0.369 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.491669e-01 | 0.260 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.366384e-01 | 0.360 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.810185e-01 | 0.551 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.899067e-01 | 0.721 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.899067e-01 | 0.721 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.850244e-01 | 0.545 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.159351e-01 | 0.500 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.095213e-01 | 0.293 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.341898e-01 | 0.476 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.991825e-01 | 0.524 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.132950e-01 | 0.504 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.667767e-01 | 0.436 | 1 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.864410e-01 | 0.729 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.331800e-01 | 0.632 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.981358e-01 | 0.526 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.981358e-01 | 0.526 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.981358e-01 | 0.526 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.219945e-01 | 0.654 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 3.575928e-01 | 0.447 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.921871e-01 | 0.716 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.921871e-01 | 0.716 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.921871e-01 | 0.716 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.870123e-01 | 0.542 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.870123e-01 | 0.542 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.194012e-01 | 0.496 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.514217e-01 | 0.454 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.514217e-01 | 0.454 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.618320e-01 | 0.336 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.328935e-01 | 0.478 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.074299e-01 | 0.295 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.140332e-01 | 0.383 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.762351e-01 | 0.425 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.010705e-01 | 0.300 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.159280e-01 | 0.287 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.289680e-01 | 0.483 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.829547e-01 | 0.548 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.482318e-01 | 0.261 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.010705e-01 | 0.300 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.194987e-01 | 0.377 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.999316e-01 | 0.398 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.850244e-01 | 0.545 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.137099e-01 | 0.383 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.011636e-01 | 0.696 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.331148e-01 | 0.477 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.870123e-01 | 0.542 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.042413e-01 | 0.393 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.519239e-01 | 0.345 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.088988e-01 | 0.293 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.373760e-01 | 0.625 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.331148e-01 | 0.477 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.042413e-01 | 0.393 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.147420e-01 | 0.668 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.870123e-01 | 0.542 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.120162e-01 | 0.385 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.618320e-01 | 0.336 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.137099e-01 | 0.383 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.137099e-01 | 0.383 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.137099e-01 | 0.383 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.829547e-01 | 0.548 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.728704e-01 | 0.325 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.606946e-01 | 0.443 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.013378e-01 | 0.396 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.624454e-01 | 0.441 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.311679e-01 | 0.480 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.913915e-01 | 0.309 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.287046e-01 | 0.483 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.519761e-01 | 0.258 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.955854e-01 | 0.529 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.955854e-01 | 0.529 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.137099e-01 | 0.383 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.437279e-01 | 0.353 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.677165e-01 | 0.572 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.382804e-01 | 0.269 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.277967e-01 | 0.278 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.424720e-01 | 0.266 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.536617e-01 | 0.343 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.720560e-01 | 0.326 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.764537e-01 | 0.322 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.140332e-01 | 0.383 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.395918e-01 | 0.357 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.965158e-01 | 0.402 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.037735e-01 | 0.298 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.203093e-01 | 0.494 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.598721e-01 | 0.337 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.937579e-01 | 0.713 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.259256e-01 | 0.646 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.090937e-01 | 0.388 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.046426e-01 | 0.516 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.579377e-01 | 0.588 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.536617e-01 | 0.343 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.331800e-01 | 0.632 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.331800e-01 | 0.632 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 2.981358e-01 | 0.526 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.899067e-01 | 0.721 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.194012e-01 | 0.496 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.829041e-01 | 0.417 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.074299e-01 | 0.295 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.074299e-01 | 0.295 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.544604e-01 | 0.256 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.440413e-01 | 0.613 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.348918e-01 | 0.475 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.275803e-01 | 0.369 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.505866e-01 | 0.346 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.818606e-01 | 0.317 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.249735e-01 | 0.372 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.159280e-01 | 0.287 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.159280e-01 | 0.287 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.544611e-01 | 0.594 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.514217e-01 | 0.454 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.572528e-01 | 0.447 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.378160e-01 | 0.624 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.382804e-01 | 0.269 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.348918e-01 | 0.475 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.973212e-01 | 0.303 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.686243e-01 | 0.329 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.575570e-01 | 0.447 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.973212e-01 | 0.303 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.973212e-01 | 0.303 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.612764e-01 | 0.336 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.544611e-01 | 0.594 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.618320e-01 | 0.336 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.328935e-01 | 0.478 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.074299e-01 | 0.295 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.849864e-01 | 0.415 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.529245e-01 | 0.344 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.277967e-01 | 0.278 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.018130e-01 | 0.299 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.571690e-01 | 0.590 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.720560e-01 | 0.326 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.310893e-01 | 0.636 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.481312e-01 | 0.458 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.868258e-01 | 0.412 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.870123e-01 | 0.542 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.514217e-01 | 0.454 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.618320e-01 | 0.336 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.728704e-01 | 0.325 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.010705e-01 | 0.300 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.010705e-01 | 0.300 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.732048e-01 | 0.325 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.676761e-01 | 0.435 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.538570e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.144098e-01 | 0.503 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.282786e-01 | 0.277 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.060192e-01 | 0.296 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.397216e-01 | 0.469 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.194012e-01 | 0.496 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.189381e-01 | 0.660 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.246840e-01 | 0.280 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.514217e-01 | 0.454 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.200801e-01 | 0.284 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.074299e-01 | 0.295 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.491669e-01 | 0.260 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.010705e-01 | 0.300 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.618320e-01 | 0.336 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.275803e-01 | 0.369 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.756954e-01 | 0.560 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.282786e-01 | 0.277 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.194012e-01 | 0.496 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.265347e-01 | 0.645 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.481150e-01 | 0.605 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.574740e-01 | 0.254 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.589274e-01 | 0.253 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.589274e-01 | 0.253 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.589274e-01 | 0.253 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.589274e-01 | 0.253 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.663788e-01 | 0.247 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.675308e-01 | 0.246 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.703759e-01 | 0.244 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.715679e-01 | 0.243 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.753315e-01 | 0.240 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.753315e-01 | 0.240 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.790070e-01 | 0.237 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.790070e-01 | 0.237 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.790070e-01 | 0.237 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.790070e-01 | 0.237 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.790070e-01 | 0.237 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.791389e-01 | 0.237 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.795946e-01 | 0.237 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 5.795946e-01 | 0.237 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 5.795946e-01 | 0.237 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.795946e-01 | 0.237 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.795946e-01 | 0.237 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.795946e-01 | 0.237 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.795946e-01 | 0.237 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.795946e-01 | 0.237 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.805070e-01 | 0.236 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.805070e-01 | 0.236 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.812772e-01 | 0.236 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.824718e-01 | 0.235 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.854377e-01 | 0.233 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.854570e-01 | 0.233 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.873697e-01 | 0.231 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.873697e-01 | 0.231 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 5.873697e-01 | 0.231 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.873697e-01 | 0.231 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.873697e-01 | 0.231 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.873697e-01 | 0.231 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.873697e-01 | 0.231 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.873697e-01 | 0.231 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.873697e-01 | 0.231 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.873697e-01 | 0.231 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.873697e-01 | 0.231 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.973085e-01 | 0.224 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.973085e-01 | 0.224 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.973085e-01 | 0.224 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.973085e-01 | 0.224 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.984997e-01 | 0.223 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.984997e-01 | 0.223 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.984997e-01 | 0.223 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.008076e-01 | 0.221 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.036706e-01 | 0.219 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.036706e-01 | 0.219 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.036706e-01 | 0.219 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.049224e-01 | 0.218 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.124507e-01 | 0.213 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.124634e-01 | 0.213 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.173910e-01 | 0.209 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.173910e-01 | 0.209 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.173910e-01 | 0.209 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.174720e-01 | 0.209 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.223373e-01 | 0.206 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.223373e-01 | 0.206 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.223373e-01 | 0.206 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.223373e-01 | 0.206 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.223373e-01 | 0.206 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.223373e-01 | 0.206 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.223373e-01 | 0.206 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.223373e-01 | 0.206 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.223373e-01 | 0.206 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.223373e-01 | 0.206 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.223373e-01 | 0.206 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.223373e-01 | 0.206 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.223373e-01 | 0.206 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.223373e-01 | 0.206 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.256011e-01 | 0.204 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.266872e-01 | 0.203 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.266872e-01 | 0.203 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.266872e-01 | 0.203 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.266872e-01 | 0.203 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.266872e-01 | 0.203 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.268039e-01 | 0.203 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.276721e-01 | 0.202 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.289544e-01 | 0.201 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.289544e-01 | 0.201 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.296720e-01 | 0.201 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.296720e-01 | 0.201 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.296720e-01 | 0.201 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.296720e-01 | 0.201 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.334877e-01 | 0.198 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.356702e-01 | 0.197 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.356702e-01 | 0.197 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.373446e-01 | 0.196 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.408317e-01 | 0.193 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.419875e-01 | 0.192 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.480075e-01 | 0.188 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.480075e-01 | 0.188 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.486512e-01 | 0.188 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.486512e-01 | 0.188 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.486512e-01 | 0.188 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.486512e-01 | 0.188 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.486512e-01 | 0.188 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.486512e-01 | 0.188 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.490869e-01 | 0.188 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.510886e-01 | 0.186 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.533305e-01 | 0.185 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.543435e-01 | 0.184 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.543435e-01 | 0.184 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.543435e-01 | 0.184 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.543435e-01 | 0.184 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.543435e-01 | 0.184 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.543435e-01 | 0.184 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.543435e-01 | 0.184 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.573318e-01 | 0.182 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.573318e-01 | 0.182 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.578575e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.603183e-01 | 0.180 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.669997e-01 | 0.176 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.678833e-01 | 0.175 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.678833e-01 | 0.175 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.678833e-01 | 0.175 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.678833e-01 | 0.175 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.695756e-01 | 0.174 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.695756e-01 | 0.174 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.695756e-01 | 0.174 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.695756e-01 | 0.174 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.695756e-01 | 0.174 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.695756e-01 | 0.174 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.695756e-01 | 0.174 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.703684e-01 | 0.174 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.703684e-01 | 0.174 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.703684e-01 | 0.174 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.703684e-01 | 0.174 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.749811e-01 | 0.171 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.749811e-01 | 0.171 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.836390e-01 | 0.165 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.836390e-01 | 0.165 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.836390e-01 | 0.165 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.836390e-01 | 0.165 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.836390e-01 | 0.165 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.836390e-01 | 0.165 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.836390e-01 | 0.165 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.836390e-01 | 0.165 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 6.836390e-01 | 0.165 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.836390e-01 | 0.165 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.867837e-01 | 0.163 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.867837e-01 | 0.163 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.891987e-01 | 0.162 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.891987e-01 | 0.162 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.894788e-01 | 0.161 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.894788e-01 | 0.161 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.894788e-01 | 0.161 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.894788e-01 | 0.161 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.912509e-01 | 0.160 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.921332e-01 | 0.160 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.935634e-01 | 0.159 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.987592e-01 | 0.156 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.005779e-01 | 0.155 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.025788e-01 | 0.153 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.025788e-01 | 0.153 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.025788e-01 | 0.153 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.025788e-01 | 0.153 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.025788e-01 | 0.153 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.029696e-01 | 0.153 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.071223e-01 | 0.151 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.071223e-01 | 0.151 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.083836e-01 | 0.150 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.083836e-01 | 0.150 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.083836e-01 | 0.150 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.083836e-01 | 0.150 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.083836e-01 | 0.150 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.083836e-01 | 0.150 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.083836e-01 | 0.150 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.099668e-01 | 0.149 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.104532e-01 | 0.148 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.104532e-01 | 0.148 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.104532e-01 | 0.148 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.104532e-01 | 0.148 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.104532e-01 | 0.148 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.104532e-01 | 0.148 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.104532e-01 | 0.148 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.104532e-01 | 0.148 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.177584e-01 | 0.144 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.178488e-01 | 0.144 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.178488e-01 | 0.144 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.178488e-01 | 0.144 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.178488e-01 | 0.144 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.178488e-01 | 0.144 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.263162e-01 | 0.139 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.263162e-01 | 0.139 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.263162e-01 | 0.139 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.263162e-01 | 0.139 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.263162e-01 | 0.139 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.263162e-01 | 0.139 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.263162e-01 | 0.139 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.263162e-01 | 0.139 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.291724e-01 | 0.137 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.291724e-01 | 0.137 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.313778e-01 | 0.136 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.323296e-01 | 0.135 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.323296e-01 | 0.135 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.349962e-01 | 0.134 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.349962e-01 | 0.134 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.349962e-01 | 0.134 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.349962e-01 | 0.134 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.349962e-01 | 0.134 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.349962e-01 | 0.134 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.349962e-01 | 0.134 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.407329e-01 | 0.130 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.416086e-01 | 0.130 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.416086e-01 | 0.130 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.418573e-01 | 0.130 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.418573e-01 | 0.130 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.433055e-01 | 0.129 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.463011e-01 | 0.127 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.463011e-01 | 0.127 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.470558e-01 | 0.127 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.519093e-01 | 0.124 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.536059e-01 | 0.123 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.557899e-01 | 0.122 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.574601e-01 | 0.121 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.574601e-01 | 0.121 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.574601e-01 | 0.121 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.574601e-01 | 0.121 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.574601e-01 | 0.121 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.574601e-01 | 0.121 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.574601e-01 | 0.121 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.574601e-01 | 0.121 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.574601e-01 | 0.121 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.574601e-01 | 0.121 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.593827e-01 | 0.120 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.593827e-01 | 0.120 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.593827e-01 | 0.120 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.593827e-01 | 0.120 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.593827e-01 | 0.120 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.593827e-01 | 0.120 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.596835e-01 | 0.119 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.596835e-01 | 0.119 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.596835e-01 | 0.119 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.616735e-01 | 0.118 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.651693e-01 | 0.116 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.724884e-01 | 0.112 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.745801e-01 | 0.111 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.745801e-01 | 0.111 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.745801e-01 | 0.111 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.745801e-01 | 0.111 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.745801e-01 | 0.111 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.745801e-01 | 0.111 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.780210e-01 | 0.109 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.780210e-01 | 0.109 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.780210e-01 | 0.109 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.780210e-01 | 0.109 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.799927e-01 | 0.108 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.847291e-01 | 0.105 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.847291e-01 | 0.105 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.847291e-01 | 0.105 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.847291e-01 | 0.105 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.870189e-01 | 0.104 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.870189e-01 | 0.104 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.889314e-01 | 0.103 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.889314e-01 | 0.103 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.892569e-01 | 0.103 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.962452e-01 | 0.099 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.964193e-01 | 0.099 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.964193e-01 | 0.099 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.968401e-01 | 0.099 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 7.968401e-01 | 0.099 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.968401e-01 | 0.099 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.968401e-01 | 0.099 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.968401e-01 | 0.099 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.968401e-01 | 0.099 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.978900e-01 | 0.098 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.024709e-01 | 0.096 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.072136e-01 | 0.093 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.072136e-01 | 0.093 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.119930e-01 | 0.090 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.140647e-01 | 0.089 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.140647e-01 | 0.089 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.140647e-01 | 0.089 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.140647e-01 | 0.089 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.140647e-01 | 0.089 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.140647e-01 | 0.089 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.140647e-01 | 0.089 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.140647e-01 | 0.089 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.143334e-01 | 0.089 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.152328e-01 | 0.089 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.152328e-01 | 0.089 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.152328e-01 | 0.089 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.152328e-01 | 0.089 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.152328e-01 | 0.089 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.167109e-01 | 0.088 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.182084e-01 | 0.087 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.184453e-01 | 0.087 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.184453e-01 | 0.087 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.184453e-01 | 0.087 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.185905e-01 | 0.087 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.185905e-01 | 0.087 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.239682e-01 | 0.084 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.240439e-01 | 0.084 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.252718e-01 | 0.083 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.272518e-01 | 0.082 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.272518e-01 | 0.082 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.272518e-01 | 0.082 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.272518e-01 | 0.082 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.277673e-01 | 0.082 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.283387e-01 | 0.082 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.298299e-01 | 0.081 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.298299e-01 | 0.081 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.298299e-01 | 0.081 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.298299e-01 | 0.081 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.298299e-01 | 0.081 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.298299e-01 | 0.081 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.298299e-01 | 0.081 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.298299e-01 | 0.081 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.298299e-01 | 0.081 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.298299e-01 | 0.081 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.303883e-01 | 0.081 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.348071e-01 | 0.078 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.379810e-01 | 0.077 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.379810e-01 | 0.077 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.385620e-01 | 0.076 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.429129e-01 | 0.074 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.442592e-01 | 0.074 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.442592e-01 | 0.074 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.442592e-01 | 0.074 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.442592e-01 | 0.074 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.442592e-01 | 0.074 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.442592e-01 | 0.074 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.442592e-01 | 0.074 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.442592e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.471519e-01 | 0.072 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.498185e-01 | 0.071 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.508365e-01 | 0.070 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.509163e-01 | 0.070 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.520440e-01 | 0.070 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.551866e-01 | 0.068 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.558681e-01 | 0.068 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.558681e-01 | 0.068 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.562272e-01 | 0.067 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.568895e-01 | 0.067 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.573853e-01 | 0.067 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.574658e-01 | 0.067 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.574658e-01 | 0.067 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.574658e-01 | 0.067 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.591698e-01 | 0.066 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.614888e-01 | 0.065 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.641462e-01 | 0.063 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.672340e-01 | 0.062 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.672340e-01 | 0.062 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.685742e-01 | 0.061 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.685742e-01 | 0.061 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.695532e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.695532e-01 | 0.061 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.695532e-01 | 0.061 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.695532e-01 | 0.061 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.695532e-01 | 0.061 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.695532e-01 | 0.061 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.699418e-01 | 0.061 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.708984e-01 | 0.060 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.720030e-01 | 0.059 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.728784e-01 | 0.059 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.728784e-01 | 0.059 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.762090e-01 | 0.057 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.773799e-01 | 0.057 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.773799e-01 | 0.057 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.773799e-01 | 0.057 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.773799e-01 | 0.057 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.773799e-01 | 0.057 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.795515e-01 | 0.056 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.806162e-01 | 0.055 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.806162e-01 | 0.055 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.806162e-01 | 0.055 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.806162e-01 | 0.055 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.806162e-01 | 0.055 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.806162e-01 | 0.055 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.806162e-01 | 0.055 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.824446e-01 | 0.054 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.856380e-01 | 0.053 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.856380e-01 | 0.053 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.856380e-01 | 0.053 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.863487e-01 | 0.052 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.876012e-01 | 0.052 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.907416e-01 | 0.050 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.909069e-01 | 0.050 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.932099e-01 | 0.049 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.932099e-01 | 0.049 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.933781e-01 | 0.049 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.933781e-01 | 0.049 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.933781e-01 | 0.049 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.933781e-01 | 0.049 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.977756e-01 | 0.047 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.977756e-01 | 0.047 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.995449e-01 | 0.046 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.995449e-01 | 0.046 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.995449e-01 | 0.046 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.995449e-01 | 0.046 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.000088e-01 | 0.046 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.000088e-01 | 0.046 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.000088e-01 | 0.046 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.000088e-01 | 0.046 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.000088e-01 | 0.046 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.000088e-01 | 0.046 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.000088e-01 | 0.046 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.000088e-01 | 0.046 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.006286e-01 | 0.045 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.006286e-01 | 0.045 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.055390e-01 | 0.043 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.055390e-01 | 0.043 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.055390e-01 | 0.043 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.074168e-01 | 0.042 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.074168e-01 | 0.042 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.084904e-01 | 0.042 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.084904e-01 | 0.042 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.084904e-01 | 0.042 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.084904e-01 | 0.042 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.084904e-01 | 0.042 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.084904e-01 | 0.042 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.088100e-01 | 0.042 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.094468e-01 | 0.041 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.112076e-01 | 0.040 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.135261e-01 | 0.039 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.135261e-01 | 0.039 | 1 | 1 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.137690e-01 | 0.039 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.149149e-01 | 0.039 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.162531e-01 | 0.038 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.162531e-01 | 0.038 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.162531e-01 | 0.038 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.162531e-01 | 0.038 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.162531e-01 | 0.038 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.162531e-01 | 0.038 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.162531e-01 | 0.038 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.165654e-01 | 0.038 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.165654e-01 | 0.038 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.165923e-01 | 0.038 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.166590e-01 | 0.038 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.182740e-01 | 0.037 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.182740e-01 | 0.037 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.197102e-01 | 0.036 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.197102e-01 | 0.036 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.202494e-01 | 0.036 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.216268e-01 | 0.035 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.216268e-01 | 0.035 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.233577e-01 | 0.035 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.233577e-01 | 0.035 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.233577e-01 | 0.035 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.246677e-01 | 0.034 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.252645e-01 | 0.034 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.252645e-01 | 0.034 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.266377e-01 | 0.033 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.269082e-01 | 0.033 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.298599e-01 | 0.032 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.298599e-01 | 0.032 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.298599e-01 | 0.032 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.298599e-01 | 0.032 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.298599e-01 | 0.032 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.298599e-01 | 0.032 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.298599e-01 | 0.032 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.301546e-01 | 0.031 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.304548e-01 | 0.031 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.304548e-01 | 0.031 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.305196e-01 | 0.031 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.311473e-01 | 0.031 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.351706e-01 | 0.029 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.351706e-01 | 0.029 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.351706e-01 | 0.029 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.351706e-01 | 0.029 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.353027e-01 | 0.029 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.358109e-01 | 0.029 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.358109e-01 | 0.029 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.358109e-01 | 0.029 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.358109e-01 | 0.029 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.366393e-01 | 0.028 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.387538e-01 | 0.027 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.391821e-01 | 0.027 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.399498e-01 | 0.027 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.412573e-01 | 0.026 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.412573e-01 | 0.026 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.412573e-01 | 0.026 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.412573e-01 | 0.026 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.412573e-01 | 0.026 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.415113e-01 | 0.026 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.429628e-01 | 0.026 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.440534e-01 | 0.025 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.453815e-01 | 0.024 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.454556e-01 | 0.024 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.454556e-01 | 0.024 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.462418e-01 | 0.024 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.462418e-01 | 0.024 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.462418e-01 | 0.024 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.462418e-01 | 0.024 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.462418e-01 | 0.024 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.465243e-01 | 0.024 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.479945e-01 | 0.023 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.485013e-01 | 0.023 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.508037e-01 | 0.022 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.508037e-01 | 0.022 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.508037e-01 | 0.022 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.508037e-01 | 0.022 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.508037e-01 | 0.022 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.508037e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.508037e-01 | 0.022 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.508037e-01 | 0.022 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.516699e-01 | 0.022 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.516699e-01 | 0.022 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.516699e-01 | 0.022 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.536099e-01 | 0.021 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.543418e-01 | 0.020 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.549787e-01 | 0.020 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.549787e-01 | 0.020 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.550963e-01 | 0.020 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.553226e-01 | 0.020 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.560051e-01 | 0.020 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.569939e-01 | 0.019 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.587996e-01 | 0.018 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.587996e-01 | 0.018 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.600615e-01 | 0.018 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.612645e-01 | 0.017 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.622965e-01 | 0.017 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.622965e-01 | 0.017 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.622965e-01 | 0.017 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.622965e-01 | 0.017 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.637321e-01 | 0.016 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.637567e-01 | 0.016 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.637567e-01 | 0.016 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.637567e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.640351e-01 | 0.016 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.654967e-01 | 0.015 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.654967e-01 | 0.015 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.666147e-01 | 0.015 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.666147e-01 | 0.015 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.666147e-01 | 0.015 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.666702e-01 | 0.015 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.672647e-01 | 0.014 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.683907e-01 | 0.014 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.684255e-01 | 0.014 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.684255e-01 | 0.014 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.688085e-01 | 0.014 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.690158e-01 | 0.014 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.690158e-01 | 0.014 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.704356e-01 | 0.013 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.711059e-01 | 0.013 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.711059e-01 | 0.013 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.711059e-01 | 0.013 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.723548e-01 | 0.012 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.727870e-01 | 0.012 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.727870e-01 | 0.012 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.733282e-01 | 0.012 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.735588e-01 | 0.012 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.735588e-01 | 0.012 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.735588e-01 | 0.012 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.735588e-01 | 0.012 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.735588e-01 | 0.012 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.735588e-01 | 0.012 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.735588e-01 | 0.012 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.741555e-01 | 0.011 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.742135e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.751969e-01 | 0.011 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.752610e-01 | 0.011 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.757455e-01 | 0.011 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.758037e-01 | 0.011 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.758037e-01 | 0.011 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.758037e-01 | 0.011 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.778580e-01 | 0.010 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.778580e-01 | 0.010 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.778580e-01 | 0.010 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.787284e-01 | 0.009 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.789126e-01 | 0.009 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.797381e-01 | 0.009 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.797381e-01 | 0.009 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.797381e-01 | 0.009 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.797381e-01 | 0.009 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.808266e-01 | 0.008 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.808266e-01 | 0.008 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.808266e-01 | 0.008 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.814586e-01 | 0.008 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.814586e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.816070e-01 | 0.008 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.816070e-01 | 0.008 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.817228e-01 | 0.008 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.828750e-01 | 0.008 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.830332e-01 | 0.007 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.830332e-01 | 0.007 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.830332e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.830332e-01 | 0.007 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.830332e-01 | 0.007 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.830623e-01 | 0.007 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.834737e-01 | 0.007 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.839705e-01 | 0.007 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.843063e-01 | 0.007 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.844741e-01 | 0.007 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.844741e-01 | 0.007 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.844741e-01 | 0.007 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.844741e-01 | 0.007 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.844741e-01 | 0.007 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.844741e-01 | 0.007 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.848964e-01 | 0.007 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.848964e-01 | 0.007 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.850365e-01 | 0.007 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.857927e-01 | 0.006 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.857927e-01 | 0.006 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.857927e-01 | 0.006 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.857927e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.857927e-01 | 0.006 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.857927e-01 | 0.006 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.860929e-01 | 0.006 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.862011e-01 | 0.006 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.864104e-01 | 0.006 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.865894e-01 | 0.006 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.868406e-01 | 0.006 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.869994e-01 | 0.006 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.869994e-01 | 0.006 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.869994e-01 | 0.006 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.869994e-01 | 0.006 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.873909e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.876631e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.881037e-01 | 0.005 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.881037e-01 | 0.005 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.881037e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.881037e-01 | 0.005 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.884365e-01 | 0.005 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.891142e-01 | 0.005 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.891142e-01 | 0.005 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.891142e-01 | 0.005 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.891142e-01 | 0.005 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.893076e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.894396e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.895438e-01 | 0.005 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.900390e-01 | 0.004 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.900390e-01 | 0.004 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.900390e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.900390e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.900390e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.901019e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.901019e-01 | 0.004 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.908384e-01 | 0.004 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.908852e-01 | 0.004 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.908852e-01 | 0.004 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.908852e-01 | 0.004 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.908852e-01 | 0.004 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.908852e-01 | 0.004 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.910918e-01 | 0.004 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.916596e-01 | 0.004 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.916596e-01 | 0.004 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.916596e-01 | 0.004 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.923682e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.923682e-01 | 0.003 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.925786e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.927411e-01 | 0.003 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.927411e-01 | 0.003 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.928007e-01 | 0.003 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.930167e-01 | 0.003 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.931493e-01 | 0.003 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.931575e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.936101e-01 | 0.003 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.936101e-01 | 0.003 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.937789e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.940063e-01 | 0.003 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.940095e-01 | 0.003 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.941531e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.942553e-01 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.943962e-01 | 0.002 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.944200e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.946500e-01 | 0.002 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.946500e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.947920e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.947920e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.948060e-01 | 0.002 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.948946e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.950988e-01 | 0.002 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.951047e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.952806e-01 | 0.002 | 1 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.955208e-01 | 0.002 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.959015e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.959959e-01 | 0.002 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.962934e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.963915e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.965035e-01 | 0.002 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.965687e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.968604e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.969487e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.971702e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.972882e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.975470e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.975951e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.975951e-01 | 0.001 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.976232e-01 | 0.001 | 1 | 1 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.977613e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.977996e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.977996e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.977996e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.979399e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.979867e-01 | 0.001 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.979867e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.981243e-01 | 0.001 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.981580e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.982059e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.982576e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.983779e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.983817e-01 | 0.001 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.985024e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.987042e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.987239e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.987834e-01 | 0.001 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.988190e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.989679e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.990114e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.990399e-01 | 0.000 | 1 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.990743e-01 | 0.000 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.990743e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.990955e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.990955e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.990955e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.991160e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.991458e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.991725e-01 | 0.000 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.992079e-01 | 0.000 | 1 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.992119e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.992429e-01 | 0.000 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.992588e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.992679e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.993073e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.993073e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.993663e-01 | 0.000 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.994342e-01 | 0.000 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.994696e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.995147e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.995560e-01 | 0.000 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.995938e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996544e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997155e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.997896e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998007e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.998177e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998474e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.998533e-01 | 0.000 | 1 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.998604e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.998683e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.998832e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.998832e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.998856e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.998931e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998931e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999167e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.999182e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.999182e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999244e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999252e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999252e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999374e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.999521e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999599e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999599e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999725e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999785e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999793e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999833e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999862e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999918e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999933e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999938e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999954e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999956e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999961e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999964e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999972e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999972e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999978e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999987e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999988e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999990e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999997e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000e+00 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 1 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.220446e-16 | 15.654 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.553513e-15 | 14.593 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.987299e-14 | 13.702 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.283862e-14 | 13.202 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.999512e-13 | 12.699 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.916512e-13 | 12.004 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.354517e-12 | 11.361 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.603540e-12 | 11.337 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.055645e-11 | 10.218 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.078893e-11 | 10.216 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.229874e-10 | 9.652 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.350242e-10 | 9.029 | 1 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.155862e-09 | 8.937 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.848000e-09 | 8.733 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.269932e-09 | 8.644 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.601542e-09 | 8.585 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.006990e-09 | 8.097 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.714522e-09 | 8.013 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.548666e-08 | 7.068 | 1 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.417194e-07 | 6.849 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.003728e-07 | 6.698 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.035923e-07 | 6.518 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.002041e-07 | 6.523 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.450429e-07 | 6.462 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.238502e-07 | 6.373 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.906416e-07 | 6.050 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.955925e-06 | 5.709 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.804940e-06 | 5.552 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.688609e-06 | 5.245 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.420235e-06 | 5.266 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.587979e-06 | 5.253 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.519527e-06 | 5.258 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.237770e-05 | 4.907 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.583188e-05 | 4.800 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.556562e-05 | 4.808 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.510697e-05 | 4.821 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.510697e-05 | 4.821 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.718531e-05 | 4.765 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.837115e-05 | 4.736 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.978991e-05 | 4.704 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.296256e-05 | 4.639 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.314220e-05 | 4.636 | 1 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.486137e-05 | 4.604 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.486137e-05 | 4.604 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.574897e-05 | 4.589 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.574897e-05 | 4.589 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.818792e-05 | 4.550 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.810308e-05 | 4.551 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.707674e-05 | 4.567 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.867466e-05 | 4.543 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.350731e-05 | 4.475 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.259555e-05 | 4.371 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.302273e-05 | 4.366 | 1 | 1 |
| Cell junction organization | R-HSA-446728 | 4.382350e-05 | 4.358 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.400416e-05 | 4.357 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.643884e-05 | 4.333 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.944671e-05 | 4.306 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.988018e-05 | 4.302 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.242948e-05 | 4.280 | 1 | 1 |
| Aggrephagy | R-HSA-9646399 | 6.207896e-05 | 4.207 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.368203e-05 | 4.196 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.327816e-05 | 4.079 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.327816e-05 | 4.079 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.934240e-05 | 4.049 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.009970e-04 | 3.996 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.068736e-04 | 3.971 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.081939e-04 | 3.966 | 1 | 1 |
| HIV Life Cycle | R-HSA-162587 | 1.196412e-04 | 3.922 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.262708e-04 | 3.899 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.274250e-04 | 3.895 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.349949e-04 | 3.870 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.422936e-04 | 3.847 | 1 | 1 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.510360e-04 | 3.821 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.568028e-04 | 3.805 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.570260e-04 | 3.804 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.600966e-04 | 3.796 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.710592e-04 | 3.767 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.856976e-04 | 3.731 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.061782e-04 | 3.686 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.066914e-04 | 3.685 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.196135e-04 | 3.658 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.277592e-04 | 3.643 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.322596e-04 | 3.634 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.470889e-04 | 3.607 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.384845e-04 | 3.623 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.347404e-04 | 3.629 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.605019e-04 | 3.584 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.819371e-04 | 3.550 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.970453e-04 | 3.527 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.896682e-04 | 3.538 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.959370e-04 | 3.529 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.177754e-04 | 3.498 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.239564e-04 | 3.490 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.258576e-04 | 3.487 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.367501e-04 | 3.473 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.525267e-04 | 3.453 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.611139e-04 | 3.442 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.727117e-04 | 3.429 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.841184e-04 | 3.416 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.995642e-04 | 3.398 | 1 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.703088e-04 | 3.328 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.707358e-04 | 3.327 | 1 | 0 |
| rRNA processing | R-HSA-72312 | 5.215574e-04 | 3.283 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.364875e-04 | 3.270 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.387345e-04 | 3.269 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.564960e-04 | 3.255 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.731326e-04 | 3.242 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.858940e-04 | 3.232 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.230849e-04 | 3.205 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.956193e-04 | 3.225 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.480815e-04 | 3.188 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.527442e-04 | 3.185 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.571296e-04 | 3.182 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.774589e-04 | 3.169 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.862559e-04 | 3.164 | 1 | 1 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.029693e-04 | 3.153 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.145889e-04 | 3.146 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.177231e-04 | 3.087 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.177231e-04 | 3.087 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.177231e-04 | 3.087 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.177231e-04 | 3.087 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.884058e-04 | 3.103 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.177231e-04 | 3.087 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.278540e-04 | 3.082 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.527937e-04 | 3.069 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.541121e-04 | 3.068 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.563591e-04 | 3.067 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.194327e-04 | 3.036 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.629602e-04 | 3.016 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 9.096737e-04 | 3.041 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.701694e-04 | 3.013 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.085103e-03 | 2.965 | 1 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.105610e-03 | 2.956 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.106780e-03 | 2.956 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.119853e-03 | 2.951 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.121232e-03 | 2.950 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.121232e-03 | 2.950 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.242706e-03 | 2.906 | 1 | 1 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.242706e-03 | 2.906 | 1 | 1 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.287263e-03 | 2.890 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.287263e-03 | 2.890 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.283821e-03 | 2.891 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.269293e-03 | 2.896 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.175845e-03 | 2.930 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.279805e-03 | 2.893 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.279805e-03 | 2.893 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.309490e-03 | 2.883 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.323219e-03 | 2.878 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.323219e-03 | 2.878 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.370068e-03 | 2.863 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.370068e-03 | 2.863 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.466512e-03 | 2.834 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.490860e-03 | 2.827 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.490860e-03 | 2.827 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.614343e-03 | 2.792 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.673478e-03 | 2.776 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.706906e-03 | 2.768 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.614343e-03 | 2.792 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.744689e-03 | 2.758 | 1 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.774483e-03 | 2.751 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.866822e-03 | 2.729 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.831674e-03 | 2.737 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.831674e-03 | 2.737 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.002479e-03 | 2.698 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.959839e-03 | 2.708 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.959839e-03 | 2.708 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.866822e-03 | 2.729 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.866822e-03 | 2.729 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.932736e-03 | 2.714 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.961824e-03 | 2.707 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.002479e-03 | 2.698 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.812734e-03 | 2.742 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.005207e-03 | 2.698 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.096717e-03 | 2.678 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.305307e-03 | 2.637 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.305307e-03 | 2.637 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.305307e-03 | 2.637 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.396983e-03 | 2.620 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.467137e-03 | 2.608 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.571434e-03 | 2.590 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.571434e-03 | 2.590 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.571434e-03 | 2.590 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.673768e-03 | 2.573 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.761827e-03 | 2.559 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.869987e-03 | 2.542 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.886409e-03 | 2.540 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.888874e-03 | 2.539 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.044423e-03 | 2.516 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.441896e-03 | 2.463 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.227776e-03 | 2.491 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.372375e-03 | 2.472 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.522430e-03 | 2.453 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.407488e-03 | 2.468 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.522430e-03 | 2.453 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.371556e-03 | 2.472 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.268947e-03 | 2.486 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.670824e-03 | 2.435 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.712480e-03 | 2.430 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.712480e-03 | 2.430 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.744105e-03 | 2.427 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.774347e-03 | 2.423 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.813830e-03 | 2.419 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.965870e-03 | 2.402 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.990623e-03 | 2.399 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.107768e-03 | 2.386 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.220546e-03 | 2.375 | 1 | 1 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.318172e-03 | 2.365 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.373116e-03 | 2.359 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.489849e-03 | 2.348 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.524783e-03 | 2.344 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.604336e-03 | 2.337 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.607489e-03 | 2.337 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.607489e-03 | 2.337 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.726460e-03 | 2.325 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.920381e-03 | 2.308 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 4.920381e-03 | 2.308 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 4.920381e-03 | 2.308 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.177139e-03 | 2.286 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.177139e-03 | 2.286 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.548473e-03 | 2.256 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.236148e-03 | 2.281 | 1 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.751072e-03 | 2.240 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.177139e-03 | 2.286 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.713875e-03 | 2.243 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.189581e-03 | 2.285 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.839825e-03 | 2.234 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.839825e-03 | 2.234 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.839825e-03 | 2.234 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.945806e-03 | 2.226 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.272030e-03 | 2.203 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.283542e-03 | 2.202 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.703382e-03 | 2.174 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.720066e-03 | 2.173 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.786052e-03 | 2.168 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.988749e-03 | 2.156 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.007735e-03 | 2.154 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.009686e-03 | 2.154 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.477444e-03 | 2.126 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.716397e-03 | 2.113 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.721596e-03 | 2.112 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.983414e-03 | 2.098 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.944354e-03 | 2.048 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.944354e-03 | 2.048 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.272557e-03 | 2.033 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.557535e-03 | 2.020 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.846336e-03 | 2.007 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.351996e-03 | 2.078 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.272557e-03 | 2.033 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 9.252759e-03 | 2.034 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.688856e-03 | 2.061 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.872251e-03 | 2.006 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.872251e-03 | 2.006 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.870001e-03 | 2.052 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.872251e-03 | 2.006 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.797299e-03 | 2.009 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.881308e-03 | 2.052 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.846336e-03 | 2.007 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.274600e-03 | 2.082 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.004347e-02 | 1.998 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.004347e-02 | 1.998 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.022931e-02 | 1.990 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.022931e-02 | 1.990 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.037260e-02 | 1.984 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.054790e-02 | 1.977 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.118448e-02 | 1.951 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.154683e-02 | 1.938 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.155120e-02 | 1.937 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.187910e-02 | 1.925 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.191373e-02 | 1.924 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.194658e-02 | 1.923 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.194658e-02 | 1.923 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.194658e-02 | 1.923 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.210305e-02 | 1.917 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.219241e-02 | 1.914 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.220191e-02 | 1.914 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.253746e-02 | 1.902 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.322192e-02 | 1.879 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.322192e-02 | 1.879 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.339848e-02 | 1.873 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.347214e-02 | 1.871 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.364739e-02 | 1.865 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.381420e-02 | 1.860 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.393919e-02 | 1.856 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.393919e-02 | 1.856 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.394742e-02 | 1.856 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.436381e-02 | 1.843 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.436381e-02 | 1.843 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.447562e-02 | 1.839 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.447562e-02 | 1.839 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.449707e-02 | 1.839 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.512830e-02 | 1.820 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.883147e-02 | 1.725 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.739269e-02 | 1.760 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.554265e-02 | 1.808 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.554265e-02 | 1.808 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.618603e-02 | 1.791 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.631714e-02 | 1.787 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.883147e-02 | 1.725 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.512830e-02 | 1.820 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.799582e-02 | 1.745 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.565900e-02 | 1.805 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.883147e-02 | 1.725 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.856327e-02 | 1.731 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.739269e-02 | 1.760 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.550904e-02 | 1.809 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.529381e-02 | 1.815 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.584343e-02 | 1.800 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.709141e-02 | 1.767 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.512830e-02 | 1.820 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.550904e-02 | 1.809 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.617747e-02 | 1.791 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.893488e-02 | 1.723 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.905347e-02 | 1.720 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.922136e-02 | 1.716 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.922136e-02 | 1.716 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.922136e-02 | 1.716 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.943994e-02 | 1.711 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.952254e-02 | 1.709 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.969490e-02 | 1.706 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.005646e-02 | 1.698 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.022302e-02 | 1.694 | 0 | 0 |
| Translation | R-HSA-72766 | 2.056918e-02 | 1.687 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.118019e-02 | 1.674 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.118548e-02 | 1.674 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.124831e-02 | 1.673 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.165826e-02 | 1.664 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.172338e-02 | 1.663 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.172338e-02 | 1.663 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.172832e-02 | 1.663 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.172832e-02 | 1.663 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.225834e-02 | 1.653 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.225834e-02 | 1.653 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.244068e-02 | 1.649 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.278631e-02 | 1.642 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.308559e-02 | 1.637 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.308559e-02 | 1.637 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.308559e-02 | 1.637 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.308559e-02 | 1.637 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.308559e-02 | 1.637 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.308559e-02 | 1.637 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.328285e-02 | 1.633 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.328285e-02 | 1.633 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.370236e-02 | 1.625 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.401569e-02 | 1.620 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.404803e-02 | 1.619 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.404803e-02 | 1.619 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.404803e-02 | 1.619 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.405491e-02 | 1.619 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.435735e-02 | 1.613 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.482672e-02 | 1.605 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.522137e-02 | 1.598 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.670642e-02 | 1.573 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.052002e-02 | 1.515 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.791583e-02 | 1.554 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.791583e-02 | 1.554 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.334278e-02 | 1.477 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.776737e-02 | 1.556 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.776737e-02 | 1.556 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.776737e-02 | 1.556 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.226751e-02 | 1.491 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.994059e-02 | 1.524 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.057847e-02 | 1.515 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.238383e-02 | 1.490 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.238383e-02 | 1.490 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.087949e-02 | 1.510 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.576912e-02 | 1.589 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.057847e-02 | 1.515 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.720492e-02 | 1.565 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.057847e-02 | 1.515 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.057847e-02 | 1.515 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.720492e-02 | 1.565 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.358756e-02 | 1.474 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.224207e-02 | 1.492 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.670642e-02 | 1.573 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.994059e-02 | 1.524 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.619723e-02 | 1.582 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.027911e-02 | 1.519 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.714428e-02 | 1.566 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.087949e-02 | 1.510 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.334278e-02 | 1.477 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.426033e-02 | 1.465 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.941109e-02 | 1.531 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.226751e-02 | 1.491 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.981044e-02 | 1.526 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.776737e-02 | 1.556 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.791583e-02 | 1.554 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.052002e-02 | 1.515 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.595261e-02 | 1.586 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.449634e-02 | 1.462 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.455795e-02 | 1.461 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.556128e-02 | 1.449 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.556128e-02 | 1.449 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.556128e-02 | 1.449 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.556128e-02 | 1.449 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.568722e-02 | 1.447 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.568722e-02 | 1.447 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.579009e-02 | 1.446 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.641271e-02 | 1.439 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.694568e-02 | 1.432 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.713739e-02 | 1.430 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.713739e-02 | 1.430 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.721650e-02 | 1.429 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.737446e-02 | 1.427 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.847025e-02 | 1.415 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.847025e-02 | 1.415 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.847025e-02 | 1.415 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.894916e-02 | 1.410 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.938236e-02 | 1.405 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.950962e-02 | 1.403 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.997476e-02 | 1.398 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.093513e-02 | 1.388 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.121983e-02 | 1.385 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.225119e-02 | 1.374 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.255282e-02 | 1.371 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.411846e-02 | 1.355 | 1 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.472638e-02 | 1.349 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.496658e-02 | 1.347 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.496658e-02 | 1.347 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.496658e-02 | 1.347 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.496658e-02 | 1.347 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.496658e-02 | 1.347 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.498675e-02 | 1.347 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.591667e-02 | 1.338 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.637716e-02 | 1.334 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.637716e-02 | 1.334 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.637716e-02 | 1.334 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.678581e-02 | 1.330 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.703952e-02 | 1.328 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.703952e-02 | 1.328 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.703952e-02 | 1.328 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.703952e-02 | 1.328 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.703952e-02 | 1.328 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.703952e-02 | 1.328 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.703952e-02 | 1.328 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.703952e-02 | 1.328 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.703952e-02 | 1.328 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.707116e-02 | 1.327 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.707116e-02 | 1.327 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.845308e-02 | 1.315 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.845308e-02 | 1.315 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.845308e-02 | 1.315 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.845308e-02 | 1.315 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.845308e-02 | 1.315 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.850396e-02 | 1.314 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.909707e-02 | 1.309 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 6.657043e-02 | 1.177 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 6.657043e-02 | 1.177 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 6.657043e-02 | 1.177 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.285124e-02 | 1.277 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.285124e-02 | 1.277 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.285124e-02 | 1.277 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.626666e-02 | 1.179 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.626704e-02 | 1.250 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.333957e-02 | 1.273 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.333957e-02 | 1.273 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.485774e-02 | 1.261 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.900493e-02 | 1.161 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.900493e-02 | 1.161 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.400750e-02 | 1.268 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.994392e-02 | 1.222 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.994392e-02 | 1.222 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.195213e-02 | 1.284 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.431929e-02 | 1.265 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.292696e-02 | 1.201 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.120527e-02 | 1.147 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.485774e-02 | 1.261 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.195213e-02 | 1.284 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.485774e-02 | 1.261 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.387225e-02 | 1.269 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.396289e-02 | 1.194 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.396289e-02 | 1.194 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.396289e-02 | 1.194 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.396289e-02 | 1.194 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.195213e-02 | 1.284 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.626540e-02 | 1.179 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.626540e-02 | 1.179 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.714719e-02 | 1.243 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.266010e-02 | 1.203 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.477937e-02 | 1.261 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.244763e-02 | 1.140 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.169092e-02 | 1.210 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.714719e-02 | 1.243 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.714719e-02 | 1.243 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.626666e-02 | 1.179 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.016502e-02 | 1.300 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.994392e-02 | 1.222 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.126571e-02 | 1.213 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.195213e-02 | 1.284 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.900493e-02 | 1.161 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.297349e-02 | 1.137 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.205731e-02 | 1.284 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.396289e-02 | 1.194 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.191612e-02 | 1.285 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.791054e-02 | 1.237 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.994392e-02 | 1.222 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.580752e-02 | 1.253 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.417172e-02 | 1.130 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.285124e-02 | 1.277 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.400750e-02 | 1.268 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.994392e-02 | 1.222 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.626540e-02 | 1.179 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.112962e-02 | 1.148 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.387225e-02 | 1.269 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.396289e-02 | 1.194 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.825258e-02 | 1.166 | 1 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.108988e-02 | 1.292 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.639329e-02 | 1.178 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.388111e-02 | 1.269 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.297349e-02 | 1.137 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.395142e-02 | 1.268 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 6.169092e-02 | 1.210 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.169092e-02 | 1.210 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.976076e-02 | 1.224 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.511264e-02 | 1.124 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.679878e-02 | 1.115 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.679878e-02 | 1.115 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.739733e-02 | 1.111 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.739733e-02 | 1.111 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.739733e-02 | 1.111 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.789835e-02 | 1.108 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.900105e-02 | 1.102 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.900105e-02 | 1.102 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.900105e-02 | 1.102 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.900105e-02 | 1.102 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.006818e-02 | 1.097 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.006818e-02 | 1.097 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.006818e-02 | 1.097 | 0 | 0 |
| Defective Base Excision Repair Associated with NEIL1 | R-HSA-9616334 | 8.030548e-02 | 1.095 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 8.030548e-02 | 1.095 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 8.030548e-02 | 1.095 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 8.030548e-02 | 1.095 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.070758e-02 | 1.093 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 8.106856e-02 | 1.091 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.106856e-02 | 1.091 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.106856e-02 | 1.091 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.106856e-02 | 1.091 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.112802e-02 | 1.091 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.112802e-02 | 1.091 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.112802e-02 | 1.091 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.157610e-02 | 1.088 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.268944e-02 | 1.083 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.427034e-02 | 1.074 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.505678e-02 | 1.070 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.520953e-02 | 1.070 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.561237e-02 | 1.067 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.668807e-02 | 1.062 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.754796e-02 | 1.058 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.792923e-02 | 1.056 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.879302e-02 | 1.052 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.879302e-02 | 1.052 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.925077e-02 | 1.049 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.925077e-02 | 1.049 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.955309e-02 | 1.048 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 9.086399e-02 | 1.042 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 9.086399e-02 | 1.042 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 9.086399e-02 | 1.042 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.086399e-02 | 1.042 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 9.086399e-02 | 1.042 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 9.086399e-02 | 1.042 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.106524e-02 | 1.041 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.129366e-02 | 1.040 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.352631e-02 | 1.029 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.381018e-02 | 1.028 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.381018e-02 | 1.028 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.419697e-02 | 1.026 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.419697e-02 | 1.026 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.432500e-02 | 1.025 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.540984e-02 | 1.020 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.635836e-02 | 1.016 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.642306e-02 | 1.016 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 9.715428e-02 | 1.013 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 9.715428e-02 | 1.013 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.715428e-02 | 1.013 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 9.715428e-02 | 1.013 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.019187e-01 | 0.992 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.019187e-01 | 0.992 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.024926e-01 | 0.989 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.030142e-01 | 0.987 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.036494e-01 | 0.984 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.101545e-01 | 0.958 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.101545e-01 | 0.958 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.103708e-01 | 0.957 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.122608e-01 | 0.950 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.126712e-01 | 0.948 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.126712e-01 | 0.948 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.144122e-01 | 0.942 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.144885e-01 | 0.941 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.153606e-01 | 0.938 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.153606e-01 | 0.938 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.153606e-01 | 0.938 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.153606e-01 | 0.938 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.172766e-01 | 0.931 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.172766e-01 | 0.931 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.172766e-01 | 0.931 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.172766e-01 | 0.931 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.180754e-01 | 0.928 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.203985e-01 | 0.919 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.212368e-01 | 0.916 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.212368e-01 | 0.916 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.212368e-01 | 0.916 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.216856e-01 | 0.915 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.541664e-01 | 0.812 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.541664e-01 | 0.812 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.541664e-01 | 0.812 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.220996e-01 | 0.653 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.220996e-01 | 0.653 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.220996e-01 | 0.653 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.220996e-01 | 0.653 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.220996e-01 | 0.653 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.220996e-01 | 0.653 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.453119e-01 | 0.838 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.453119e-01 | 0.838 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.045870e-01 | 0.689 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.045870e-01 | 0.689 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.045870e-01 | 0.689 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.519726e-01 | 0.818 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.351350e-01 | 0.629 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.351350e-01 | 0.629 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.351350e-01 | 0.629 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.295314e-01 | 0.888 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.295314e-01 | 0.888 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.295314e-01 | 0.888 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.295314e-01 | 0.888 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.141299e-01 | 0.669 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.463314e-01 | 0.835 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.463314e-01 | 0.835 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.463314e-01 | 0.835 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.359348e-01 | 0.627 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.359348e-01 | 0.627 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.332949e-01 | 0.875 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.447515e-01 | 0.611 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.044665e-01 | 0.689 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.932262e-01 | 0.714 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.664810e-01 | 0.779 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.086003e-01 | 0.681 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.550192e-01 | 0.810 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.868406e-01 | 0.729 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.868406e-01 | 0.729 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.759145e-01 | 0.755 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.868406e-01 | 0.729 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.396139e-01 | 0.855 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.759145e-01 | 0.755 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.598613e-01 | 0.796 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.921929e-01 | 0.716 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.442326e-01 | 0.841 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.351350e-01 | 0.629 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.359348e-01 | 0.627 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.320120e-01 | 0.879 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.320120e-01 | 0.879 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 1.720348e-01 | 0.764 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.141299e-01 | 0.669 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.095210e-01 | 0.679 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.266886e-01 | 0.897 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.869903e-01 | 0.728 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.300676e-01 | 0.886 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.519726e-01 | 0.818 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.918579e-01 | 0.717 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.442326e-01 | 0.841 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.922312e-01 | 0.716 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.541664e-01 | 0.812 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.141299e-01 | 0.669 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.044665e-01 | 0.689 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.044665e-01 | 0.689 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.461336e-01 | 0.609 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.042621e-01 | 0.690 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.359348e-01 | 0.627 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.342200e-01 | 0.630 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.519726e-01 | 0.818 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.627719e-01 | 0.788 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.011646e-01 | 0.696 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.259753e-01 | 0.900 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.453119e-01 | 0.838 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 2.351350e-01 | 0.629 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.351350e-01 | 0.629 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.857150e-01 | 0.731 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.079107e-01 | 0.682 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.630973e-01 | 0.788 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.320120e-01 | 0.879 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.304895e-01 | 0.637 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.823397e-01 | 0.739 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.304895e-01 | 0.637 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.462172e-01 | 0.835 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.722092e-01 | 0.764 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.349008e-01 | 0.629 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.174797e-01 | 0.663 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.353605e-01 | 0.869 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.343902e-01 | 0.872 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.707131e-01 | 0.768 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.541664e-01 | 0.812 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.541664e-01 | 0.812 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.541664e-01 | 0.812 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.220996e-01 | 0.653 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.220996e-01 | 0.653 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.220996e-01 | 0.653 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.745393e-01 | 0.758 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.295314e-01 | 0.888 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.332949e-01 | 0.875 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.332949e-01 | 0.875 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.447515e-01 | 0.611 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.759145e-01 | 0.755 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.359348e-01 | 0.627 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.246379e-01 | 0.904 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.897433e-01 | 0.722 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.380458e-01 | 0.860 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.598613e-01 | 0.796 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.453119e-01 | 0.838 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.266886e-01 | 0.897 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.630973e-01 | 0.788 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.166780e-01 | 0.664 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.431131e-01 | 0.614 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.044665e-01 | 0.689 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.327333e-01 | 0.877 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.337532e-01 | 0.874 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.327333e-01 | 0.877 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.327333e-01 | 0.877 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.639744e-01 | 0.785 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.443044e-01 | 0.841 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.637424e-01 | 0.786 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.402479e-01 | 0.853 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.251605e-01 | 0.903 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.220996e-01 | 0.653 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.759145e-01 | 0.755 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.269614e-01 | 0.644 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.917467e-01 | 0.717 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.080338e-01 | 0.682 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.708347e-01 | 0.767 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.606012e-01 | 0.794 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.408700e-01 | 0.618 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.598613e-01 | 0.796 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.918579e-01 | 0.717 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.759145e-01 | 0.755 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.461336e-01 | 0.609 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.086003e-01 | 0.681 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.502626e-01 | 0.823 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.524946e-01 | 0.817 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.815186e-01 | 0.741 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.254602e-01 | 0.647 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.269614e-01 | 0.644 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.045870e-01 | 0.689 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.442948e-01 | 0.612 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.606012e-01 | 0.794 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.917467e-01 | 0.717 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.897433e-01 | 0.722 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.216298e-01 | 0.654 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.045870e-01 | 0.689 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.141299e-01 | 0.669 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.353605e-01 | 0.869 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.295314e-01 | 0.888 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.759145e-01 | 0.755 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.216298e-01 | 0.654 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.359348e-01 | 0.627 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.924866e-01 | 0.716 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.402479e-01 | 0.853 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.639824e-01 | 0.785 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.678444e-01 | 0.775 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.759145e-01 | 0.755 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.927926e-01 | 0.715 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.729057e-01 | 0.762 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.174797e-01 | 0.663 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.479584e-01 | 0.606 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.548320e-01 | 0.594 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.548320e-01 | 0.594 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.581003e-01 | 0.588 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.581003e-01 | 0.588 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.581003e-01 | 0.588 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.581003e-01 | 0.588 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.616748e-01 | 0.582 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.628356e-01 | 0.580 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.628356e-01 | 0.580 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.628356e-01 | 0.580 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.635612e-01 | 0.579 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.658698e-01 | 0.575 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.659094e-01 | 0.575 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.659094e-01 | 0.575 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.659094e-01 | 0.575 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.659094e-01 | 0.575 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.659094e-01 | 0.575 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.659094e-01 | 0.575 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.659094e-01 | 0.575 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 2.659094e-01 | 0.575 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.659094e-01 | 0.575 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.659094e-01 | 0.575 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 2.659094e-01 | 0.575 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.710830e-01 | 0.567 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.711450e-01 | 0.567 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.720050e-01 | 0.565 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.720050e-01 | 0.565 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.792300e-01 | 0.554 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.805253e-01 | 0.552 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.805253e-01 | 0.552 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.811594e-01 | 0.551 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.829580e-01 | 0.548 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.845804e-01 | 0.546 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.845804e-01 | 0.546 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.845804e-01 | 0.546 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.845804e-01 | 0.546 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.845804e-01 | 0.546 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.845804e-01 | 0.546 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.845804e-01 | 0.546 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.845804e-01 | 0.546 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.845804e-01 | 0.546 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.857687e-01 | 0.544 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.886595e-01 | 0.540 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.915376e-01 | 0.535 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.915376e-01 | 0.535 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.915376e-01 | 0.535 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.925809e-01 | 0.534 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.933782e-01 | 0.533 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.933782e-01 | 0.533 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.953531e-01 | 0.530 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.966772e-01 | 0.528 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.966772e-01 | 0.528 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.966772e-01 | 0.528 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.966772e-01 | 0.528 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.966772e-01 | 0.528 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.966772e-01 | 0.528 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.969314e-01 | 0.527 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.996698e-01 | 0.523 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.996698e-01 | 0.523 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.996698e-01 | 0.523 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.004201e-01 | 0.522 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.004201e-01 | 0.522 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.031146e-01 | 0.518 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.031146e-01 | 0.518 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.031146e-01 | 0.518 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.031146e-01 | 0.518 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.031146e-01 | 0.518 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.034461e-01 | 0.518 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.045777e-01 | 0.516 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.069671e-01 | 0.513 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.079822e-01 | 0.511 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.136813e-01 | 0.504 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.148327e-01 | 0.502 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.148886e-01 | 0.502 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.183156e-01 | 0.497 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.191331e-01 | 0.496 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.193323e-01 | 0.496 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.195626e-01 | 0.495 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.198322e-01 | 0.495 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.256850e-01 | 0.487 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.257794e-01 | 0.487 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.257794e-01 | 0.487 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.257794e-01 | 0.487 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.257794e-01 | 0.487 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.257794e-01 | 0.487 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.257794e-01 | 0.487 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.272409e-01 | 0.485 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.272409e-01 | 0.485 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.272409e-01 | 0.485 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.272409e-01 | 0.485 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.273128e-01 | 0.485 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.293508e-01 | 0.482 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.309822e-01 | 0.480 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.313881e-01 | 0.480 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.313881e-01 | 0.480 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.342309e-01 | 0.476 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.364422e-01 | 0.473 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.370474e-01 | 0.472 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.370474e-01 | 0.472 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.372284e-01 | 0.472 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.417007e-01 | 0.466 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.419828e-01 | 0.466 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.419828e-01 | 0.466 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.420462e-01 | 0.466 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.420462e-01 | 0.466 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.420462e-01 | 0.466 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.420462e-01 | 0.466 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.482962e-01 | 0.458 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.484376e-01 | 0.458 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.484376e-01 | 0.458 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.484376e-01 | 0.458 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.484376e-01 | 0.458 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.558184e-01 | 0.449 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.561104e-01 | 0.448 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.574351e-01 | 0.447 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.574351e-01 | 0.447 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.574351e-01 | 0.447 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.574351e-01 | 0.447 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.583348e-01 | 0.446 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.583348e-01 | 0.446 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.583348e-01 | 0.446 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.632246e-01 | 0.440 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.685504e-01 | 0.434 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.702096e-01 | 0.432 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.710137e-01 | 0.431 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.710137e-01 | 0.431 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.711374e-01 | 0.430 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.784158e-01 | 0.422 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.810251e-01 | 0.419 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.846007e-01 | 0.415 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.846007e-01 | 0.415 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.848110e-01 | 0.415 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.871220e-01 | 0.412 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.871220e-01 | 0.412 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.871220e-01 | 0.412 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.871220e-01 | 0.412 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.871220e-01 | 0.412 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.871220e-01 | 0.412 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.871220e-01 | 0.412 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.871220e-01 | 0.412 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.871220e-01 | 0.412 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 3.871220e-01 | 0.412 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.880238e-01 | 0.411 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.910817e-01 | 0.408 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.910817e-01 | 0.408 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.916607e-01 | 0.407 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.933007e-01 | 0.405 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.933007e-01 | 0.405 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 3.948992e-01 | 0.404 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.948992e-01 | 0.404 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.948992e-01 | 0.404 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.948992e-01 | 0.404 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.948992e-01 | 0.404 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.948992e-01 | 0.404 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 3.948992e-01 | 0.404 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.948992e-01 | 0.404 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.948992e-01 | 0.404 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.981875e-01 | 0.400 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.008103e-01 | 0.397 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.060264e-01 | 0.391 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.060409e-01 | 0.391 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.069188e-01 | 0.390 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.119300e-01 | 0.385 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.119300e-01 | 0.385 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.119300e-01 | 0.385 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.119300e-01 | 0.385 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.149717e-01 | 0.382 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.156499e-01 | 0.381 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.156499e-01 | 0.381 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 4.156499e-01 | 0.381 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.161884e-01 | 0.381 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.161884e-01 | 0.381 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.161884e-01 | 0.381 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.161884e-01 | 0.381 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.161884e-01 | 0.381 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.267099e-01 | 0.370 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.294001e-01 | 0.367 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.304343e-01 | 0.366 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.304343e-01 | 0.366 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.375913e-01 | 0.359 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.375913e-01 | 0.359 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.400979e-01 | 0.356 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.400979e-01 | 0.356 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.435095e-01 | 0.353 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.435095e-01 | 0.353 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.435095e-01 | 0.353 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.435095e-01 | 0.353 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.435095e-01 | 0.353 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.435095e-01 | 0.353 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.435095e-01 | 0.353 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.435095e-01 | 0.353 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.445426e-01 | 0.352 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.445426e-01 | 0.352 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.445426e-01 | 0.352 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.445426e-01 | 0.352 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.487790e-01 | 0.348 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.487790e-01 | 0.348 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.517810e-01 | 0.345 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.559762e-01 | 0.341 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.559762e-01 | 0.341 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.559762e-01 | 0.341 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.567677e-01 | 0.340 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.592127e-01 | 0.338 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.592127e-01 | 0.338 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 4.592127e-01 | 0.338 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.621298e-01 | 0.335 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.669322e-01 | 0.331 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.719295e-01 | 0.326 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.721114e-01 | 0.326 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.721114e-01 | 0.326 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.721114e-01 | 0.326 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.721114e-01 | 0.326 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.804697e-01 | 0.318 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.804697e-01 | 0.318 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.804697e-01 | 0.318 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.804697e-01 | 0.318 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.805548e-01 | 0.318 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.824221e-01 | 0.317 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.882174e-01 | 0.311 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.882174e-01 | 0.311 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.882174e-01 | 0.311 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.882174e-01 | 0.311 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 4.882174e-01 | 0.311 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 4.882174e-01 | 0.311 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.882174e-01 | 0.311 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.882174e-01 | 0.311 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.882174e-01 | 0.311 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.882174e-01 | 0.311 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 4.882174e-01 | 0.311 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 4.882174e-01 | 0.311 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 4.882174e-01 | 0.311 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.882174e-01 | 0.311 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.882174e-01 | 0.311 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.882174e-01 | 0.311 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 4.898205e-01 | 0.310 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.988380e-01 | 0.302 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.988380e-01 | 0.302 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.988380e-01 | 0.302 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.988380e-01 | 0.302 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 4.988380e-01 | 0.302 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.013234e-01 | 0.300 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.013234e-01 | 0.300 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.023686e-01 | 0.299 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.033591e-01 | 0.298 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.033591e-01 | 0.298 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.044902e-01 | 0.297 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.159848e-01 | 0.287 | 1 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.179924e-01 | 0.286 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.217401e-01 | 0.283 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.246800e-01 | 0.280 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.246800e-01 | 0.280 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.246800e-01 | 0.280 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.246800e-01 | 0.280 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.246800e-01 | 0.280 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.287219e-01 | 0.277 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.293359e-01 | 0.276 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.293359e-01 | 0.276 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.293359e-01 | 0.276 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.293359e-01 | 0.276 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.293359e-01 | 0.276 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.293359e-01 | 0.276 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.293359e-01 | 0.276 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.293359e-01 | 0.276 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.293359e-01 | 0.276 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.293359e-01 | 0.276 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.293359e-01 | 0.276 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.293359e-01 | 0.276 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.302163e-01 | 0.276 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.339476e-01 | 0.273 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.370802e-01 | 0.270 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.371449e-01 | 0.270 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.416910e-01 | 0.266 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.416910e-01 | 0.266 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.416910e-01 | 0.266 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.496069e-01 | 0.260 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.496069e-01 | 0.260 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.496069e-01 | 0.260 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.496069e-01 | 0.260 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.496069e-01 | 0.260 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.496069e-01 | 0.260 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.538854e-01 | 0.257 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.538854e-01 | 0.257 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.538854e-01 | 0.257 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.590474e-01 | 0.253 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.611519e-01 | 0.251 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.611519e-01 | 0.251 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.611519e-01 | 0.251 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.611519e-01 | 0.251 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.641223e-01 | 0.249 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.671531e-01 | 0.246 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.671531e-01 | 0.246 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.671531e-01 | 0.246 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.671531e-01 | 0.246 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.671531e-01 | 0.246 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.671531e-01 | 0.246 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.671531e-01 | 0.246 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.671531e-01 | 0.246 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.671531e-01 | 0.246 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.671531e-01 | 0.246 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.671531e-01 | 0.246 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.671531e-01 | 0.246 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.671531e-01 | 0.246 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.671531e-01 | 0.246 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.735989e-01 | 0.241 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.735989e-01 | 0.241 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.796572e-01 | 0.237 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.801029e-01 | 0.236 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.801029e-01 | 0.236 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.801029e-01 | 0.236 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.801029e-01 | 0.236 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.805791e-01 | 0.236 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.841167e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.864890e-01 | 0.232 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.864890e-01 | 0.232 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.864890e-01 | 0.232 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.864890e-01 | 0.232 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.920263e-01 | 0.228 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.966454e-01 | 0.224 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.966454e-01 | 0.224 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.966454e-01 | 0.224 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.966454e-01 | 0.224 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.966454e-01 | 0.224 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.966454e-01 | 0.224 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.983858e-01 | 0.223 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.019338e-01 | 0.220 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.019338e-01 | 0.220 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.019338e-01 | 0.220 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.019338e-01 | 0.220 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.019338e-01 | 0.220 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.019338e-01 | 0.220 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.019338e-01 | 0.220 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.019338e-01 | 0.220 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.019338e-01 | 0.220 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.019338e-01 | 0.220 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.019338e-01 | 0.220 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.019338e-01 | 0.220 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.019338e-01 | 0.220 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.019338e-01 | 0.220 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.022593e-01 | 0.220 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.155704e-01 | 0.211 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.164147e-01 | 0.210 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.164147e-01 | 0.210 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.167011e-01 | 0.210 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.176600e-01 | 0.209 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.187434e-01 | 0.208 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.187434e-01 | 0.208 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.187434e-01 | 0.208 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.187434e-01 | 0.208 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.187434e-01 | 0.208 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.200014e-01 | 0.208 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.326820e-01 | 0.199 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.326820e-01 | 0.199 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.326820e-01 | 0.199 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.326820e-01 | 0.199 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.337540e-01 | 0.198 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.337540e-01 | 0.198 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.337540e-01 | 0.198 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.339216e-01 | 0.198 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.339216e-01 | 0.198 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.339216e-01 | 0.198 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.339216e-01 | 0.198 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.339216e-01 | 0.198 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.339216e-01 | 0.198 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.339216e-01 | 0.198 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.339216e-01 | 0.198 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.339216e-01 | 0.198 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.339216e-01 | 0.198 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.339216e-01 | 0.198 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.339216e-01 | 0.198 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.339216e-01 | 0.198 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.357645e-01 | 0.197 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.383586e-01 | 0.195 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.398965e-01 | 0.194 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.398965e-01 | 0.194 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.398965e-01 | 0.194 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.398965e-01 | 0.194 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.398965e-01 | 0.194 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.473179e-01 | 0.189 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.473179e-01 | 0.189 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.473179e-01 | 0.189 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.473179e-01 | 0.189 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.562969e-01 | 0.183 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.596652e-01 | 0.181 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.596652e-01 | 0.181 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.601053e-01 | 0.180 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.601139e-01 | 0.180 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.601139e-01 | 0.180 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.633407e-01 | 0.178 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.633407e-01 | 0.178 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.633407e-01 | 0.178 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.633407e-01 | 0.178 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.633407e-01 | 0.178 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.633407e-01 | 0.178 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.633407e-01 | 0.178 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 6.633407e-01 | 0.178 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 6.633407e-01 | 0.178 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.633407e-01 | 0.178 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.633407e-01 | 0.178 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.633407e-01 | 0.178 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.667692e-01 | 0.176 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.667692e-01 | 0.176 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.747452e-01 | 0.171 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.754105e-01 | 0.170 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.794093e-01 | 0.168 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.824411e-01 | 0.166 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.844008e-01 | 0.165 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.844008e-01 | 0.165 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 6.844008e-01 | 0.165 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.888604e-01 | 0.162 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.888604e-01 | 0.162 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.903973e-01 | 0.161 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.903973e-01 | 0.161 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.903973e-01 | 0.161 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.903973e-01 | 0.161 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.903973e-01 | 0.161 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.903973e-01 | 0.161 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.903973e-01 | 0.161 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 6.903973e-01 | 0.161 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.903973e-01 | 0.161 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 6.903973e-01 | 0.161 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.903973e-01 | 0.161 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 6.903973e-01 | 0.161 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.903973e-01 | 0.161 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.903973e-01 | 0.161 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.917721e-01 | 0.160 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.932565e-01 | 0.159 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.963036e-01 | 0.157 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.978002e-01 | 0.156 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.978002e-01 | 0.156 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.010866e-01 | 0.154 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.036167e-01 | 0.153 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 7.121206e-01 | 0.147 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.145606e-01 | 0.146 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.152808e-01 | 0.146 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.152808e-01 | 0.146 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.152808e-01 | 0.146 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.152808e-01 | 0.146 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.152808e-01 | 0.146 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.152808e-01 | 0.146 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.152808e-01 | 0.146 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.152808e-01 | 0.146 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.152808e-01 | 0.146 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.152808e-01 | 0.146 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.153075e-01 | 0.146 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.153075e-01 | 0.146 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.153075e-01 | 0.146 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.191702e-01 | 0.143 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.191702e-01 | 0.143 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.191702e-01 | 0.143 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.247099e-01 | 0.140 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.261371e-01 | 0.139 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.261371e-01 | 0.139 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.301330e-01 | 0.137 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.319543e-01 | 0.136 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.319543e-01 | 0.136 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.381657e-01 | 0.132 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.381657e-01 | 0.132 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.381657e-01 | 0.132 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.381657e-01 | 0.132 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.381657e-01 | 0.132 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.381657e-01 | 0.132 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.381657e-01 | 0.132 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.381657e-01 | 0.132 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.381657e-01 | 0.132 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.396132e-01 | 0.131 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 7.396132e-01 | 0.131 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.396132e-01 | 0.131 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.477658e-01 | 0.126 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.525574e-01 | 0.123 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.531148e-01 | 0.123 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.535217e-01 | 0.123 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.592125e-01 | 0.120 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.592125e-01 | 0.120 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.592125e-01 | 0.120 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.592125e-01 | 0.120 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.592125e-01 | 0.120 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.627687e-01 | 0.118 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.627687e-01 | 0.118 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.627687e-01 | 0.118 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.627687e-01 | 0.118 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.627687e-01 | 0.118 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.627687e-01 | 0.118 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.649789e-01 | 0.116 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.685412e-01 | 0.114 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.719657e-01 | 0.112 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.768884e-01 | 0.110 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.768884e-01 | 0.110 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.769908e-01 | 0.110 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.769908e-01 | 0.110 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.769908e-01 | 0.110 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.769908e-01 | 0.110 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.785687e-01 | 0.109 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.785687e-01 | 0.109 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.785687e-01 | 0.109 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.785687e-01 | 0.109 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.785687e-01 | 0.109 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.785687e-01 | 0.109 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.785687e-01 | 0.109 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.785687e-01 | 0.109 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.785687e-01 | 0.109 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.785687e-01 | 0.109 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.785687e-01 | 0.109 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.785687e-01 | 0.109 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.785687e-01 | 0.109 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.821917e-01 | 0.107 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.845053e-01 | 0.105 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.882970e-01 | 0.103 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.882970e-01 | 0.103 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.904607e-01 | 0.102 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.904607e-01 | 0.102 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.904607e-01 | 0.102 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.911967e-01 | 0.102 | 1 | 0 |
| Neddylation | R-HSA-8951664 | 7.919482e-01 | 0.101 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.921248e-01 | 0.101 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.963699e-01 | 0.099 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.963699e-01 | 0.099 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.963699e-01 | 0.099 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.963699e-01 | 0.099 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.963699e-01 | 0.099 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.963699e-01 | 0.099 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.963699e-01 | 0.099 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.963699e-01 | 0.099 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.978293e-01 | 0.098 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.983830e-01 | 0.098 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.992170e-01 | 0.097 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.992170e-01 | 0.097 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.032072e-01 | 0.095 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.032072e-01 | 0.095 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.067373e-01 | 0.093 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.108973e-01 | 0.091 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.108973e-01 | 0.091 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.127410e-01 | 0.090 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.127410e-01 | 0.090 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.127410e-01 | 0.090 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.127410e-01 | 0.090 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.127410e-01 | 0.090 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.127410e-01 | 0.090 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.127410e-01 | 0.090 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.127410e-01 | 0.090 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.127410e-01 | 0.090 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.152598e-01 | 0.089 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.152598e-01 | 0.089 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.176572e-01 | 0.087 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.186009e-01 | 0.087 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.197511e-01 | 0.086 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.266474e-01 | 0.083 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.277969e-01 | 0.082 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.277969e-01 | 0.082 | 1 | 1 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.277969e-01 | 0.082 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.277969e-01 | 0.082 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.277969e-01 | 0.082 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.277969e-01 | 0.082 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.277969e-01 | 0.082 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.282604e-01 | 0.082 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.291740e-01 | 0.081 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.291740e-01 | 0.081 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.345264e-01 | 0.079 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.345264e-01 | 0.079 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.364332e-01 | 0.078 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.364332e-01 | 0.078 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.373991e-01 | 0.077 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.412777e-01 | 0.075 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.416430e-01 | 0.075 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.416430e-01 | 0.075 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.416430e-01 | 0.075 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.416430e-01 | 0.075 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.475435e-01 | 0.072 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.475435e-01 | 0.072 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.475435e-01 | 0.072 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.475435e-01 | 0.072 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.541103e-01 | 0.068 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.543767e-01 | 0.068 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.543767e-01 | 0.068 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.543767e-01 | 0.068 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.543767e-01 | 0.068 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.543767e-01 | 0.068 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.543767e-01 | 0.068 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.556669e-01 | 0.068 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.571088e-01 | 0.067 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.571088e-01 | 0.067 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.571088e-01 | 0.067 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.571088e-01 | 0.067 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.571088e-01 | 0.067 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.571088e-01 | 0.067 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.571088e-01 | 0.067 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.630870e-01 | 0.064 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.660791e-01 | 0.062 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.660870e-01 | 0.062 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.660870e-01 | 0.062 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.660870e-01 | 0.062 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.660870e-01 | 0.062 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.660870e-01 | 0.062 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.661223e-01 | 0.062 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.661223e-01 | 0.062 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.705822e-01 | 0.060 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.746110e-01 | 0.058 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.746110e-01 | 0.058 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.746110e-01 | 0.058 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.768564e-01 | 0.057 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.768564e-01 | 0.057 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.768564e-01 | 0.057 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.768564e-01 | 0.057 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.768564e-01 | 0.057 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.768564e-01 | 0.057 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.768564e-01 | 0.057 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.768564e-01 | 0.057 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.768564e-01 | 0.057 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.768564e-01 | 0.057 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.768564e-01 | 0.057 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.777124e-01 | 0.057 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.788863e-01 | 0.056 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.826010e-01 | 0.054 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.828177e-01 | 0.054 | 1 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.844914e-01 | 0.053 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.867602e-01 | 0.052 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.867602e-01 | 0.052 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.867602e-01 | 0.052 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 8.867602e-01 | 0.052 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.867602e-01 | 0.052 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.867602e-01 | 0.052 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.901175e-01 | 0.051 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.901175e-01 | 0.051 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.901175e-01 | 0.051 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.924670e-01 | 0.049 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.932992e-01 | 0.049 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.942423e-01 | 0.049 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.958681e-01 | 0.048 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 8.958681e-01 | 0.048 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 8.958681e-01 | 0.048 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.958681e-01 | 0.048 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.958681e-01 | 0.048 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 8.958681e-01 | 0.048 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.958681e-01 | 0.048 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 8.958681e-01 | 0.048 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.962790e-01 | 0.048 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.971851e-01 | 0.047 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.971851e-01 | 0.047 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.974057e-01 | 0.047 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.015680e-01 | 0.045 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.022942e-01 | 0.045 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.038272e-01 | 0.044 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.038272e-01 | 0.044 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.038272e-01 | 0.044 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.042439e-01 | 0.044 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.076752e-01 | 0.042 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.076752e-01 | 0.042 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.076752e-01 | 0.042 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.083676e-01 | 0.042 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.093403e-01 | 0.041 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.100665e-01 | 0.041 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.119465e-01 | 0.040 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.119465e-01 | 0.040 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.119465e-01 | 0.040 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.119465e-01 | 0.040 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.119465e-01 | 0.040 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.159249e-01 | 0.038 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.159994e-01 | 0.038 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.190299e-01 | 0.037 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.190299e-01 | 0.037 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.190299e-01 | 0.037 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.190299e-01 | 0.037 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.190299e-01 | 0.037 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.190299e-01 | 0.037 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.205433e-01 | 0.036 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.208279e-01 | 0.036 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.214232e-01 | 0.036 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.214232e-01 | 0.036 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.214232e-01 | 0.036 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.232363e-01 | 0.035 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.232363e-01 | 0.035 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.239486e-01 | 0.034 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.242965e-01 | 0.034 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.255439e-01 | 0.034 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.255439e-01 | 0.034 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.255439e-01 | 0.034 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.255439e-01 | 0.034 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.255439e-01 | 0.034 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.255439e-01 | 0.034 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.255439e-01 | 0.034 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.255439e-01 | 0.034 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.255439e-01 | 0.034 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.288706e-01 | 0.032 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.315342e-01 | 0.031 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.315342e-01 | 0.031 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.315342e-01 | 0.031 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.315342e-01 | 0.031 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.315342e-01 | 0.031 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.315342e-01 | 0.031 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.337331e-01 | 0.030 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.348705e-01 | 0.029 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.353054e-01 | 0.029 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.358646e-01 | 0.029 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.370429e-01 | 0.028 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.370429e-01 | 0.028 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.394636e-01 | 0.027 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.402027e-01 | 0.027 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.402027e-01 | 0.027 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.421086e-01 | 0.026 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.421086e-01 | 0.026 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.454993e-01 | 0.024 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.454993e-01 | 0.024 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.458726e-01 | 0.024 | 1 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.467670e-01 | 0.024 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.467670e-01 | 0.024 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.479105e-01 | 0.023 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.491043e-01 | 0.023 | 1 | 0 |
| Kidney development | R-HSA-9830369 | 9.497265e-01 | 0.022 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.510509e-01 | 0.022 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.510509e-01 | 0.022 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.510509e-01 | 0.022 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.549902e-01 | 0.020 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.566720e-01 | 0.019 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.577199e-01 | 0.019 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.577199e-01 | 0.019 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.582342e-01 | 0.019 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.582933e-01 | 0.019 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.586127e-01 | 0.018 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.605070e-01 | 0.017 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.606001e-01 | 0.017 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.614106e-01 | 0.017 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.619439e-01 | 0.017 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 9.619439e-01 | 0.017 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.637950e-01 | 0.016 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.650071e-01 | 0.015 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.652314e-01 | 0.015 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.652314e-01 | 0.015 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.657449e-01 | 0.015 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.674855e-01 | 0.014 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.680782e-01 | 0.014 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.680782e-01 | 0.014 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.704142e-01 | 0.013 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.704142e-01 | 0.013 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.704142e-01 | 0.013 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.715874e-01 | 0.013 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.722078e-01 | 0.012 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.727960e-01 | 0.012 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.727960e-01 | 0.012 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.727960e-01 | 0.012 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.736082e-01 | 0.012 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.741947e-01 | 0.011 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.741947e-01 | 0.011 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.742405e-01 | 0.011 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.749863e-01 | 0.011 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.749863e-01 | 0.011 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.749863e-01 | 0.011 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.759694e-01 | 0.011 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.763427e-01 | 0.010 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.770003e-01 | 0.010 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.780053e-01 | 0.010 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.784255e-01 | 0.009 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.791983e-01 | 0.009 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.805552e-01 | 0.009 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.805552e-01 | 0.009 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.806130e-01 | 0.009 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.806130e-01 | 0.009 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.821211e-01 | 0.008 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.821211e-01 | 0.008 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.848408e-01 | 0.007 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.848530e-01 | 0.007 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.848850e-01 | 0.007 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.848850e-01 | 0.007 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.861024e-01 | 0.006 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.861024e-01 | 0.006 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.864865e-01 | 0.006 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.872219e-01 | 0.006 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.872219e-01 | 0.006 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.891359e-01 | 0.005 | 1 | 1 |
| Metabolism of cofactors | R-HSA-8978934 | 9.899008e-01 | 0.004 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.899008e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.900680e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.908682e-01 | 0.004 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.912760e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.913366e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.914894e-01 | 0.004 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.916040e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.917157e-01 | 0.004 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.922805e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.922805e-01 | 0.003 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.929026e-01 | 0.003 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.934995e-01 | 0.003 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.939622e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.939622e-01 | 0.003 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.940005e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.948325e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.948675e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.951675e-01 | 0.002 | 1 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.956798e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.963288e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.963288e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.966688e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.966688e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.969374e-01 | 0.001 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.971843e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.971885e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.974114e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.979885e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.981154e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.981508e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.985632e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.986097e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.986791e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.989331e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.990742e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.992646e-01 | 0.000 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.993613e-01 | 0.000 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.993613e-01 | 0.000 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.993613e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.994331e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.994821e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.995577e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.995921e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.996814e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.996940e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.997547e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.997674e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998249e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998404e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998484e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.998520e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998626e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998750e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998750e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.998750e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998944e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998951e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999227e-01 | 0.000 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.999246e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999273e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999389e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999441e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999616e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999676e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999693e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999747e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999804e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999953e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999958e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999985e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999994e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999996e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999998e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.000000e+00 | 0.000 | 1 | 1 |